JP2019517596A5 - - Google Patents

Download PDF

Info

Publication number: JP2019517596A5
Authority: JP; Japan
Prior art keywords: dicyano; thio; phenylacetamide; amino; ethyl
Prior art date: 2017-06-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP2019517187A

Other languages

English (en)

Japanese (ja)

Other versions

JP7051829B2 (ja

JP2019517596A (ja

Filing date

2017-06-13

Publication date

2020-07-27

2017-06-13 Application filed filed Critical

2017-06-13 Priority claimed from PCT/IB2017/053511 external-priority patent/WO2017216727A1/en

2019-06-24 Publication of JP2019517596A publication Critical patent/JP2019517596A/ja

2020-07-27 Publication of JP2019517596A5 publication Critical patent/JP2019517596A5/ja

2022-04-11 Application granted granted Critical

2022-04-11 Publication of JP7051829B2 publication Critical patent/JP7051829B2/ja

Status Active legal-status Critical Current

2037-06-13 Anticipated expiration legal-status Critical

Links

125000000217 alkyl group Chemical group 0.000 claims 230
-1 -OR e Chemical group 0.000 claims 167
125000001424 substituent group Chemical group 0.000 claims 132
235000019000 fluorine Nutrition 0.000 claims 131
229910052731 fluorine Inorganic materials 0.000 claims 130
239000011737 fluorine Substances 0.000 claims 130
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 129
125000000592 heterocycloalkyl group Chemical group 0.000 claims 89
125000000753 cycloalkyl group Chemical group 0.000 claims 85
125000003118 aryl group Chemical group 0.000 claims 75
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 69
229910052801 chlorine Inorganic materials 0.000 claims 69
239000000460 chlorine Substances 0.000 claims 69
125000004093 cyano group Chemical group *C#N 0.000 claims 69
125000001072 heteroaryl group Chemical group 0.000 claims 67
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 58
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 52
125000003545 alkoxy group Chemical group 0.000 claims 48
125000004043 oxo group Chemical group O=* 0.000 claims 39
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 35
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 32
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 32
229910052794 bromium Inorganic materials 0.000 claims 32
150000001875 compounds Chemical class 0.000 claims 30
239000008194 pharmaceutical composition Substances 0.000 claims 30
150000003839 salts Chemical class 0.000 claims 27
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 24
125000003566 oxetanyl group Chemical group 0.000 claims 21
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 20
229910052739 hydrogen Inorganic materials 0.000 claims 17
239000001257 hydrogen Substances 0.000 claims 17
125000002883 imidazolyl group Chemical group 0.000 claims 17
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 17
206010028980 Neoplasm Diseases 0.000 claims 16
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 16
125000003386 piperidinyl group Chemical group 0.000 claims 16
241000124008 Mammalia Species 0.000 claims 15
NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 claims 15
229910052757 nitrogen Inorganic materials 0.000 claims 14
201000011510 cancer Diseases 0.000 claims 13
229940002612 prodrug Drugs 0.000 claims 12
239000000651 prodrug Substances 0.000 claims 12
125000000719 pyrrolidinyl group Chemical group 0.000 claims 12
125000002393 azetidinyl group Chemical group 0.000 claims 11
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 11
125000004193 piperazinyl group Chemical group 0.000 claims 11
125000003226 pyrazolyl group Chemical group 0.000 claims 11
125000002785 azepinyl group Chemical group 0.000 claims 10
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 10
150000002431 hydrogen Chemical class 0.000 claims 10
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 10
208000007056 sickle cell anemia Diseases 0.000 claims 10
229910052717 sulfur Inorganic materials 0.000 claims 10
201000010099 disease Diseases 0.000 claims 9
125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 8
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
229910052760 oxygen Inorganic materials 0.000 claims 8
208000011580 syndromic disease Diseases 0.000 claims 8
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 7
125000005842 heteroatom Chemical group 0.000 claims 7
IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 7
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 7
RKAYIEFADPAEOO-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)C)SC(C(=O)N)C1=CC=CC=C1 RKAYIEFADPAEOO-UHFFFAOYSA-N 0.000 claims 6
LNEBGQBVQRBDMK-UHFFFAOYSA-N 2-[6-(4-amino-4-methylpiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1(CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C LNEBGQBVQRBDMK-UHFFFAOYSA-N 0.000 claims 6
125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 claims 6
208000006402 Ductal Carcinoma Diseases 0.000 claims 6
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 6
208000005017 glioblastoma Diseases 0.000 claims 6
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 6
125000002757 morpholinyl group Chemical group 0.000 claims 6
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 6
230000002159 abnormal effect Effects 0.000 claims 5
208000009956 adenocarcinoma Diseases 0.000 claims 5
125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 5
125000006311 cyclobutyl amino group Chemical group [H]N(*)C1([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 5
125000000160 oxazolidinyl group Chemical group 0.000 claims 5
150000003852 triazoles Chemical class 0.000 claims 5
AYZZJIDLBKXRKQ-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[2-(hydroxymethyl)morpholin-4-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(OCC1)CO)SC(C(=O)N)C1=CC=CC=C1 AYZZJIDLBKXRKQ-UHFFFAOYSA-N 0.000 claims 4
QVROPBZLGMQZIH-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[3-(dimethylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(CCC1)N(C)C)SC(C(=O)N)C1=CC=CC=C1 QVROPBZLGMQZIH-UHFFFAOYSA-N 0.000 claims 4
JZULSOHKMKJPIN-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(dimethylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)C)SC(C(=O)N)C1=CC=C(C=C1)F JZULSOHKMKJPIN-UHFFFAOYSA-N 0.000 claims 4
AYNULTGWVKTAEP-UHFFFAOYSA-N 2-[6-(3-aminoazetidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CN(C1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N AYNULTGWVKTAEP-UHFFFAOYSA-N 0.000 claims 4
QNAWNFWIFHMERM-UHFFFAOYSA-N 2-[6-[(2-amino-2-oxoethyl)-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(CN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C)=O QNAWNFWIFHMERM-UHFFFAOYSA-N 0.000 claims 4
CWUNMSSHZVRHPS-UHFFFAOYSA-N 2-[[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]-methylamino]ethyl dihydrogen phosphate Chemical compound P(=O)(OCCN(C)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)(O)O CWUNMSSHZVRHPS-UHFFFAOYSA-N 0.000 claims 4
125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 4
206010068873 Adenosquamous cell carcinoma Diseases 0.000 claims 4
KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 4
206010018404 Glucagonoma Diseases 0.000 claims 4
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-Valine Natural products CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 4
208000018020 Sickle cell-beta-thalassemia disease syndrome Diseases 0.000 claims 4
206010043391 Thalassaemia beta Diseases 0.000 claims 4
208000006336 acinar cell carcinoma Diseases 0.000 claims 4
201000008395 adenosquamous carcinoma Diseases 0.000 claims 4
KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims 4
208000034737 hemoglobinopathy Diseases 0.000 claims 4
239000003112 inhibitor Substances 0.000 claims 4
206010022498 insulinoma Diseases 0.000 claims 4
208000032839 leukemia Diseases 0.000 claims 4
201000001441 melanoma Diseases 0.000 claims 4
NJYYWQHQUOODDL-UHFFFAOYSA-N oxetane-3-carboxamide Chemical compound NC(=O)C1COC1 NJYYWQHQUOODDL-UHFFFAOYSA-N 0.000 claims 4
208000021255 pancreatic insulinoma Diseases 0.000 claims 4
239000000546 pharmaceutical excipient Substances 0.000 claims 4
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 4
KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 claims 4
TWLBWWRTVQHOCK-RDTXWAMCSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[(3R)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H](CC1)O)S[C@@H](C(=O)N)C1=CC=CC=C1 TWLBWWRTVQHOCK-RDTXWAMCSA-N 0.000 claims 3
TWLBWWRTVQHOCK-KBXCAEBGSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)S[C@@H](C(=O)N)C1=CC=CC=C1 TWLBWWRTVQHOCK-KBXCAEBGSA-N 0.000 claims 3
TWLBWWRTVQHOCK-KSSFIOAISA-N (2S)-2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)S[C@H](C(=O)N)C1=CC=CC=C1 TWLBWWRTVQHOCK-KSSFIOAISA-N 0.000 claims 3
WUVHZNRMARLTQL-UHFFFAOYSA-N 2-[3,5-dicyano-4-(furan-2-yl)-6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C=1OC=CC=1)C#N)N1CCN(CCC1)C)SC(C(=O)N)C1=CC=CC=C1 WUVHZNRMARLTQL-UHFFFAOYSA-N 0.000 claims 3
TWLBWWRTVQHOCK-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(3-hydroxypyrrolidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(CC1)O)SC(C(=O)N)C1=CC=CC=C1 TWLBWWRTVQHOCK-UHFFFAOYSA-N 0.000 claims 3
TWLBWWRTVQHOCK-IKJXHCRLSA-N 2-[3,5-dicyano-4-ethyl-6-[(3R)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H](CC1)O)SC(C(=O)N)C1=CC=CC=C1 TWLBWWRTVQHOCK-IKJXHCRLSA-N 0.000 claims 3
TWLBWWRTVQHOCK-PIVQAISJSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)SC(C(=O)N)C1=CC=CC=C1 TWLBWWRTVQHOCK-PIVQAISJSA-N 0.000 claims 3
206010003571 Astrocytoma Diseases 0.000 claims 3
208000012609 Cowden disease Diseases 0.000 claims 3
201000002847 Cowden syndrome Diseases 0.000 claims 3
208000032612 Glial tumor Diseases 0.000 claims 3
201000010915 Glioblastoma multiforme Diseases 0.000 claims 3
206010018338 Glioma Diseases 0.000 claims 3
208000008770 Multiple Hamartoma Syndrome Diseases 0.000 claims 3
206010039491 Sarcoma Diseases 0.000 claims 3
210000004556 brain Anatomy 0.000 claims 3
239000003795 chemical substances by application Substances 0.000 claims 3
125000006317 cyclopropyl amino group Chemical group 0.000 claims 3
239000003814 drug Substances 0.000 claims 3
210000003128 head Anatomy 0.000 claims 3
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 3
210000003734 kidney Anatomy 0.000 claims 3
210000004185 liver Anatomy 0.000 claims 3
210000003739 neck Anatomy 0.000 claims 3
210000001672 ovary Anatomy 0.000 claims 3
210000000496 pancreas Anatomy 0.000 claims 3
210000002307 prostate Anatomy 0.000 claims 3
210000001685 thyroid gland Anatomy 0.000 claims 3
125000001425 triazolyl group Chemical group 0.000 claims 3
CITLODUGFLYYPD-GOSISDBHSA-N (2R)-2-(3,5-dicyano-4-ethyl-6-morpholin-4-ylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCOCC1)S[C@@H](C(=O)N)C1=CC=CC=C1 CITLODUGFLYYPD-GOSISDBHSA-N 0.000 claims 2
XBGYNCRALWAEIG-HSZRJFAPSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-(4-pyrrolidin-1-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1CCCC1)S[C@@H](C(=O)N)C1=CC=CC=C1 XBGYNCRALWAEIG-HSZRJFAPSA-N 0.000 claims 2
YFYRJDAXIJWXRZ-IIBYNOLFSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[(2R)-2-[[(2-hydroxyacetyl)amino]methyl]morpholin-4-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC([C@@H](C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1C[C@H](OCC1)CNC(CO)=O)C#N)CC)C#N)=O YFYRJDAXIJWXRZ-IIBYNOLFSA-N 0.000 claims 2
NAXQRMHGLARATP-XMSQKQJNSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[(3R)-3-hydroxy-3-(hydroxymethyl)pyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@](CC1)(CO)O)S[C@@H](C(=O)N)C1=CC=CC=C1 NAXQRMHGLARATP-XMSQKQJNSA-N 0.000 claims 2
NAXQRMHGLARATP-GCJKJVERSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxy-3-(hydroxymethyl)pyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@](CC1)(CO)O)S[C@@H](C(=O)N)C1=CC=CC=C1 NAXQRMHGLARATP-GCJKJVERSA-N 0.000 claims 2
LACBFVVSYQHECW-KPZWWZAWSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-(2,4-difluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)S[C@@H](C(=O)N)C1=C(C=C(C=C1)F)F LACBFVVSYQHECW-KPZWWZAWSA-N 0.000 claims 2
XOYGSTAJAGOUHB-QGZVFWFLSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[2-hydroxyethyl(methyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCO)S[C@@H](C(=O)N)C1=CC=CC=C1 XOYGSTAJAGOUHB-QGZVFWFLSA-N 0.000 claims 2
SEPYRSOYBZMXCN-GOSISDBHSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[3-hydroxypropyl(methyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCCO)S[C@@H](C(=O)N)C1=CC=CC=C1 SEPYRSOYBZMXCN-GOSISDBHSA-N 0.000 claims 2
KYIDEMYYLVDDEB-DNVCBOLYSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[methyl-[(3R)-oxolan-3-yl]amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N([C@H]1COCC1)C)S[C@@H](C(=O)N)C1=CC=CC=C1 KYIDEMYYLVDDEB-DNVCBOLYSA-N 0.000 claims 2
KIEQQZZDWUNUQK-MRXNPFEDSA-N (2R)-2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)S[C@@H](C(=O)N)C1=CC=CC=C1 KIEQQZZDWUNUQK-MRXNPFEDSA-N 0.000 claims 2
MELQQCMEXPGRLW-OAQYLSRUSA-N (2R)-2-[3,5-dicyano-6-[4-(dimethylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)C)S[C@@H](C(=O)N)C1=CC=CC=C1 MELQQCMEXPGRLW-OAQYLSRUSA-N 0.000 claims 2
KNKHRZYILDZLRE-LJQANCHMSA-N (2R)-2-[6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N KNKHRZYILDZLRE-LJQANCHMSA-N 0.000 claims 2
PMWNNSZNZVXNKL-DNVCBOLYSA-N (2R)-2-[6-[(2R)-2-(aminomethyl)morpholin-4-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC[C@H]1OCCN(C1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N PMWNNSZNZVXNKL-DNVCBOLYSA-N 0.000 claims 2
XUJZHDXEUODIPV-XMSQKQJNSA-N (2R)-2-[6-[(3R)-3-(aminomethyl)-3-hydroxypyrrolidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC[C@]1(CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)O XUJZHDXEUODIPV-XMSQKQJNSA-N 0.000 claims 2
PXKHEPMNNUEAGS-GUDVDZBRSA-N (2R)-2-[6-[(3R,4R)-4-amino-3-fluoropiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@H]1[C@@H](CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F PXKHEPMNNUEAGS-GUDVDZBRSA-N 0.000 claims 2
QISXCBQMUSSXPW-GUDVDZBRSA-N (2R)-2-[6-[(3R,4R)-4-amino-3-hydroxypiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@H]1[C@@H](CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)O QISXCBQMUSSXPW-GUDVDZBRSA-N 0.000 claims 2
PXKHEPMNNUEAGS-CEXWTWQISA-N (2R)-2-[6-[(3R,4S)-4-amino-3-fluoropiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@@H]1[C@@H](CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F PXKHEPMNNUEAGS-CEXWTWQISA-N 0.000 claims 2
SLFVOEJIFPFHPQ-GCJKJVERSA-N (2R)-2-[6-[(3S)-3-(aminomethyl)-3-fluoropyrrolidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC[C@@]1(CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F SLFVOEJIFPFHPQ-GCJKJVERSA-N 0.000 claims 2
XUJZHDXEUODIPV-GCJKJVERSA-N (2R)-2-[6-[(3S)-3-(aminomethyl)-3-hydroxypyrrolidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC[C@@]1(CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)O XUJZHDXEUODIPV-GCJKJVERSA-N 0.000 claims 2
PXKHEPMNNUEAGS-IPMKNSEASA-N (2R)-2-[6-[(3S,4R)-4-amino-3-fluoropiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@H]1[C@H](CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F PXKHEPMNNUEAGS-IPMKNSEASA-N 0.000 claims 2
QISXCBQMUSSXPW-CEXWTWQISA-N (2R)-2-[6-[(3S,4R)-4-amino-3-hydroxypiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@H]1[C@H](CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)O QISXCBQMUSSXPW-CEXWTWQISA-N 0.000 claims 2
PXKHEPMNNUEAGS-GBESFXJTSA-N (2R)-2-[6-[(3S,4S)-4-amino-3-fluoropiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@@H]1[C@H](CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F PXKHEPMNNUEAGS-GBESFXJTSA-N 0.000 claims 2
RJMRXCDNOIGHBN-OAQYLSRUSA-N (2R)-2-[[3,5-dicyano-4-ethyl-6-(4-ethyl-1,4-diazepan-1-yl)pyridin-2-yl]amino]-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CC)N[C@@H](C(=O)N)C1=CC=CC=C1 RJMRXCDNOIGHBN-OAQYLSRUSA-N 0.000 claims 2
DXUKXJSINKNGTD-OAQYLSRUSA-N (2R)-2-[[3,5-dicyano-4-ethyl-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]pyridin-2-yl]amino]-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CCO)N[C@@H](C(=O)N)C1=CC=CC=C1 DXUKXJSINKNGTD-OAQYLSRUSA-N 0.000 claims 2
SEKLCRJQUCYDPG-AREMUKBSSA-N (2R)-2-[[3,5-dicyano-4-ethyl-6-[4-(3-pyrrolidin-1-ylpropyl)-1,4-diazepan-1-yl]pyridin-2-yl]amino]-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CCCN1CCCC1)N[C@@H](C(=O)N)C1=CC=CC=C1 SEKLCRJQUCYDPG-AREMUKBSSA-N 0.000 claims 2
HSKVBTYMHPVTJH-LJQANCHMSA-N (2R)-2-[[3,5-dicyano-6-(1,4-diazepan-1-yl)-4-ethylpyridin-2-yl]amino]-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCNCCC1)N[C@@H](C(=O)N)C1=CC=CC=C1 HSKVBTYMHPVTJH-LJQANCHMSA-N 0.000 claims 2
OKWMELWZORVWFL-QSVWIEALSA-N (2R)-2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-cyclopropylpyridin-2-yl]azetidin-3-yl]-3-hydroxypropanamide Chemical compound N[C@@H](C(=O)NC1CN(C1)C1=NC(=C(C(=C1C#N)C1CC1)C#N)SC(C(=O)N)C1=CC=CC=C1)CO OKWMELWZORVWFL-QSVWIEALSA-N 0.000 claims 2
YGJJZMSBZVUVKQ-JGHKVMFLSA-N (2R)-2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-cyclopropylpyridin-2-yl]piperidin-4-yl]propanamide Chemical compound N[C@@H](C(=O)NC1CCN(CC1)C1=NC(=C(C(=C1C#N)C1CC1)C#N)SC(C(=O)N)C1=CC=CC=C1)C YGJJZMSBZVUVKQ-JGHKVMFLSA-N 0.000 claims 2
UKIZLJJTXDLHOT-VQCQRNETSA-N (2R)-2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidin-4-yl]-3-hydroxypropanamide Chemical compound N[C@@H](C(=O)NC1CCN(CC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)CO UKIZLJJTXDLHOT-VQCQRNETSA-N 0.000 claims 2
ZKTQBLPUIOTRRR-RBFZIWAESA-N (2R)-2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidin-4-yl]propanamide Chemical compound N[C@@H](C(=O)NC1CCN(CC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)C ZKTQBLPUIOTRRR-RBFZIWAESA-N 0.000 claims 2
KIEQQZZDWUNUQK-QKHLJXARSA-N (2R)-2-deuterio-2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)S[C@](C(=O)N)([2H])C1=CC=CC=C1 KIEQQZZDWUNUQK-QKHLJXARSA-N 0.000 claims 2
KYIDEMYYLVDDEB-BEFAXECRSA-N (2S)-2-[3,5-dicyano-4-ethyl-6-[methyl-[(3R)-oxolan-3-yl]amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N([C@H]1COCC1)C)S[C@H](C(=O)N)C1=CC=CC=C1 KYIDEMYYLVDDEB-BEFAXECRSA-N 0.000 claims 2
KNKHRZYILDZLRE-IBGZPJMESA-N (2S)-2-[6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)S[C@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N KNKHRZYILDZLRE-IBGZPJMESA-N 0.000 claims 2
PXKHEPMNNUEAGS-QYZOEREBSA-N (2S)-2-[6-[(3R,4S)-4-amino-3-fluoropiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@@H]1[C@@H](CN(CC1)C1=C(C(=C(C(=N1)S[C@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F PXKHEPMNNUEAGS-QYZOEREBSA-N 0.000 claims 2
PXKHEPMNNUEAGS-OTWHNJEPSA-N (2S)-2-[6-[(3S,4R)-4-amino-3-fluoropiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@H]1[C@H](CN(CC1)C1=C(C(=C(C(=N1)S[C@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F PXKHEPMNNUEAGS-OTWHNJEPSA-N 0.000 claims 2
OKWMELWZORVWFL-LROBGIAVSA-N (2S)-2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-cyclopropylpyridin-2-yl]azetidin-3-yl]-3-hydroxypropanamide Chemical compound N[C@H](C(=O)NC1CN(C1)C1=NC(=C(C(=C1C#N)C1CC1)C#N)SC(C(=O)N)C1=CC=CC=C1)CO OKWMELWZORVWFL-LROBGIAVSA-N 0.000 claims 2
YGJJZMSBZVUVKQ-UEDXYCIISA-N (2S)-2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-cyclopropylpyridin-2-yl]piperidin-4-yl]propanamide Chemical compound N[C@H](C(=O)NC1CCN(CC1)C1=NC(=C(C(=C1C#N)C1CC1)C#N)SC(C(=O)N)C1=CC=CC=C1)C YGJJZMSBZVUVKQ-UEDXYCIISA-N 0.000 claims 2
UKIZLJJTXDLHOT-BGERDNNASA-N (2S)-2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidin-4-yl]-3-hydroxypropanamide Chemical compound N[C@H](C(=O)NC1CCN(CC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)CO UKIZLJJTXDLHOT-BGERDNNASA-N 0.000 claims 2
ZKTQBLPUIOTRRR-ZDGMYTEDSA-N (2S)-2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidin-4-yl]propanamide Chemical compound N[C@H](C(=O)NC1CCN(CC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)C ZKTQBLPUIOTRRR-ZDGMYTEDSA-N 0.000 claims 2
ITEPIAUQBCBCAW-UHFFFAOYSA-N 1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]-4-hydroxypiperidine-4-carboxamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1CCC(CC1)(C(=O)N)O)C#N)CC)C#N)=O ITEPIAUQBCBCAW-UHFFFAOYSA-N 0.000 claims 2
JLJIZFOSRBABJL-UHFFFAOYSA-N 1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidine-4-carboxamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1CCC(CC1)C(=O)N)C#N)CC)C#N)=O JLJIZFOSRBABJL-UHFFFAOYSA-N 0.000 claims 2
DUJZKRZORJLCLM-UHFFFAOYSA-N 1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]pyrrolidine-3-carboxamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1CC(CC1)C(=O)N)C#N)CC)C#N)=O DUJZKRZORJLCLM-UHFFFAOYSA-N 0.000 claims 2
KYURKRFGKGRNNG-UHFFFAOYSA-N 2-(3,5-dichloro-4-ethyl-6-piperazin-1-ylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound ClC=1C(=NC(=C(C=1CC)Cl)N1CCNCC1)SC(C(=O)N)C1=CC=CC=C1 KYURKRFGKGRNNG-UHFFFAOYSA-N 0.000 claims 2
DHNDYNWUHXEKBW-UHFFFAOYSA-N 2-(3,5-dicyano-4,6-diethylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)CC)SC(C(=O)N)C1=CC=CC=C1 DHNDYNWUHXEKBW-UHFFFAOYSA-N 0.000 claims 2
AFWBPDSPAKJTII-UHFFFAOYSA-N 2-(3,5-dicyano-4-cyclopropyl-6-morpholin-4-ylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCOCC1)SC(C(=O)N)C1=CC=CC=C1 AFWBPDSPAKJTII-UHFFFAOYSA-N 0.000 claims 2
VMDVTANOJNOWGA-UHFFFAOYSA-N 2-(3,5-dicyano-4-cyclopropyl-6-morpholin-4-ylpyridin-2-yl)sulfanyl-2-pyridin-4-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCOCC1)SC(C(=O)N)C1=CC=NC=C1 VMDVTANOJNOWGA-UHFFFAOYSA-N 0.000 claims 2
JEEKMGZTZSORLV-UHFFFAOYSA-N 2-(3,5-dicyano-4-cyclopropyl-6-piperazin-1-ylpyridin-2-yl)sulfanyl-2-pyridin-4-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCNCC1)SC(C(=O)N)C1=CC=NC=C1 JEEKMGZTZSORLV-UHFFFAOYSA-N 0.000 claims 2
ZLCZVATZPMXDKH-UHFFFAOYSA-N 2-(3,5-dicyano-4-ethoxy-6-methylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1OCC)C#N)C)SC(C(=O)N)C1=CC=CC=C1 ZLCZVATZPMXDKH-UHFFFAOYSA-N 0.000 claims 2
JSCBRTMDYAZVCC-UHFFFAOYSA-N 2-(3,5-dicyano-4-ethyl-6-methylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)C)SC(C(=O)N)C1=CC=CC=C1 JSCBRTMDYAZVCC-UHFFFAOYSA-N 0.000 claims 2
CITLODUGFLYYPD-UHFFFAOYSA-N 2-(3,5-dicyano-4-ethyl-6-morpholin-4-ylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCOCC1)SC(C(=O)N)C1=CC=CC=C1 CITLODUGFLYYPD-UHFFFAOYSA-N 0.000 claims 2
VEEUARNCRSRLMI-UHFFFAOYSA-N 2-(3,5-dicyano-4-ethyl-6-piperazin-1-ylpyridin-2-yl)sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCNCC1)SC(C(=O)N)C1=CC=C(C=C1)F VEEUARNCRSRLMI-UHFFFAOYSA-N 0.000 claims 2
ZWCZXCXGYPKPTE-UHFFFAOYSA-N 2-(3,5-dicyano-4-ethyl-6-piperazin-1-ylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCNCC1)SC(C(=O)N)C1=CC=CC=C1 ZWCZXCXGYPKPTE-UHFFFAOYSA-N 0.000 claims 2
QKTOMHMXAKONNE-UHFFFAOYSA-N 2-(3,5-dicyano-4-ethyl-6-piperazin-1-ylpyridin-2-yl)sulfanyl-2-thiophen-3-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCNCC1)SC(C(=O)N)C1=CSC=C1 QKTOMHMXAKONNE-UHFFFAOYSA-N 0.000 claims 2
JWWLGAVPWYJCBJ-UHFFFAOYSA-N 2-(3-benzoylphenyl)-2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanylacetamide Chemical compound C(C1=CC=CC=C1)(=O)C=1C=C(C=CC=1)C(C(=O)N)SC1=NC(=C(C(=C1C#N)CC)C#N)N1CCN(CCC1)CCO JWWLGAVPWYJCBJ-UHFFFAOYSA-N 0.000 claims 2
XZSDQGMQWFSLJW-UHFFFAOYSA-N 2-(3-cyano-4-ethyl-5-methyl-6-piperazin-1-ylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C)N1CCNCC1)SC(C(=O)N)C1=CC=CC=C1 XZSDQGMQWFSLJW-UHFFFAOYSA-N 0.000 claims 2
PTQOINFPPNUTEJ-UHFFFAOYSA-N 2-(4-benzoylphenyl)-2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanylacetamide Chemical compound C(C1=CC=CC=C1)(=O)C1=CC=C(C=C1)C(C(=O)N)SC1=NC(=C(C(=C1C#N)CC)C#N)N1CCN(CCC1)CCO PTQOINFPPNUTEJ-UHFFFAOYSA-N 0.000 claims 2
STOCLPJPNSTUAB-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanylacetamide Chemical compound ClC1=CC=C(C=C1)C(C(=O)N)SC1=NC(=C(C(=C1C#N)CC)C#N)N(C)C STOCLPJPNSTUAB-UHFFFAOYSA-N 0.000 claims 2
BIKGIIMWQRGVJH-UHFFFAOYSA-N 2-[3,5-dichloro-4-ethyl-6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound ClC=1C(=NC(=C(C=1CC)Cl)N1CCN(CCC1)C)SC(C(=O)N)C1=CC=CC=C1 BIKGIIMWQRGVJH-UHFFFAOYSA-N 0.000 claims 2
RXFPUVXNVRCHKD-UHFFFAOYSA-N 2-[3,5-dichloro-4-ethyl-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound ClC=1C(=NC(=C(C=1CC)Cl)N1CCN(CCC1)CCO)SC(C(=O)N)C1=CC=CC=C1 RXFPUVXNVRCHKD-UHFFFAOYSA-N 0.000 claims 2
PAUHBDXOZUTHBS-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCNCCC1)SC(C(=O)N)C1=CC=CC=C1 PAUHBDXOZUTHBS-UHFFFAOYSA-N 0.000 claims 2
WPLNPAJJUPRGNG-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-pyridin-4-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCNCCC1)SC(C(=O)N)C1=CC=NC=C1 WPLNPAJJUPRGNG-UHFFFAOYSA-N 0.000 claims 2
UUOZMGVKHLFJBA-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(1,4-diazepan-1-yl)pyridin-2-yl]sulfanylpropanamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCNCCC1)SC(C(=O)N)C UUOZMGVKHLFJBA-UHFFFAOYSA-N 0.000 claims 2
IYEHEHCKPMJGMI-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(2,6-dimethylmorpholin-4-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(OC(C1)C)C)SC(C(=O)N)C1=CC=CC=C1 IYEHEHCKPMJGMI-UHFFFAOYSA-N 0.000 claims 2
JPVHKFLIWFESRW-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(3-hydroxyazetidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(C1)O)SC(C(=O)N)C1=CC=CC=C1 JPVHKFLIWFESRW-UHFFFAOYSA-N 0.000 claims 2
WZQFJKWYRNLKDK-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(3-hydroxypiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(CCC1)O)SC(C(=O)N)C1=CC=CC=C1 WZQFJKWYRNLKDK-UHFFFAOYSA-N 0.000 claims 2
KSEUXNSAPLLRCN-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(3-hydroxypyrrolidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(CC1)O)SC(C(=O)N)C1=CC=CC=C1 KSEUXNSAPLLRCN-UHFFFAOYSA-N 0.000 claims 2
RKGZAWAZEJZLRD-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(3-methylpiperazin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(NCC1)C)SC(C(=O)N)C1=CC=CC=C1 RKGZAWAZEJZLRD-UHFFFAOYSA-N 0.000 claims 2
GSMZCJKTZVHVCP-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(3-oxopiperazin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(NCC1)=O)SC(C(=O)N)C1=CC=CC=C1 GSMZCJKTZVHVCP-UHFFFAOYSA-N 0.000 claims 2
IPIAHZTYERRXQS-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(4-ethyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCN(CCC1)CC)SC(C(=O)N)C1=CC=CC=C1 IPIAHZTYERRXQS-UHFFFAOYSA-N 0.000 claims 2
IWCAZNGYRSJFIX-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(4-methyl-5-oxo-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCN(C(CC1)=O)C)SC(C(=O)N)C1=CC=CC=C1 IWCAZNGYRSJFIX-UHFFFAOYSA-N 0.000 claims 2
MHUDTXOVWMDNQJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(4-morpholin-4-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCC(CC1)N1CCOCC1)SC(C(=O)N)C1=CC=CC=C1 MHUDTXOVWMDNQJ-UHFFFAOYSA-N 0.000 claims 2
SMKAEMALCGLLMQ-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(4-pyrrolidin-1-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCC(CC1)N1CCCC1)SC(C(=O)N)C1=CC=CC=C1 SMKAEMALCGLLMQ-UHFFFAOYSA-N 0.000 claims 2
BBCJAXNYDGYRPG-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(5-oxo-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCNC(CC1)=O)SC(C(=O)N)C1=CC=CC=C1 BBCJAXNYDGYRPG-UHFFFAOYSA-N 0.000 claims 2
SQSPRRWZSIZYKO-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(dimethylamino)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N(C)C)SC(C(=O)N)C1=CC=CC=C1 SQSPRRWZSIZYKO-UHFFFAOYSA-N 0.000 claims 2
UEXXHPWRYIUMFR-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(dimethylamino)pyridin-2-yl]sulfanyl-2-pyridin-4-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N(C)C)SC(C(=O)N)C1=CC=NC=C1 UEXXHPWRYIUMFR-UHFFFAOYSA-N 0.000 claims 2
WZQFJKWYRNLKDK-QRIPLOBPSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[(3R)-3-hydroxypiperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1C[C@@H](CCC1)O)SC(C(=O)N)C1=CC=CC=C1 WZQFJKWYRNLKDK-QRIPLOBPSA-N 0.000 claims 2
WZQFJKWYRNLKDK-DJZRFWRSSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[(3S)-3-hydroxypiperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1C[C@H](CCC1)O)SC(C(=O)N)C1=CC=CC=C1 WZQFJKWYRNLKDK-DJZRFWRSSA-N 0.000 claims 2
SQIPHLMGNXRJAF-PIVQAISJSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-pyridin-4-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1C[C@H](CC1)O)SC(C(=O)N)C1=CC=NC=C1 SQIPHLMGNXRJAF-PIVQAISJSA-N 0.000 claims 2
JJLWDWRURXASKJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[2-hydroxyethyl(methyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N(C)CCO)SC(C(=O)N)C1=CC=CC=C1 JJLWDWRURXASKJ-UHFFFAOYSA-N 0.000 claims 2
VRKPCWYOSROMON-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[3-(hydroxymethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(NCC1)CO)SC(C(=O)N)C1=CC=CC=C1 VRKPCWYOSROMON-UHFFFAOYSA-N 0.000 claims 2
MTKDQKSITHIDHV-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[3-(methylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(CCC1)NC)SC(C(=O)N)C1=CC=CC=C1 MTKDQKSITHIDHV-UHFFFAOYSA-N 0.000 claims 2
UIELGJHJGGLZRH-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[4-(2-hydroxyethylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCC(CC1)NCCO)SC(C(=O)N)C1=CC=CC=C1 UIELGJHJGGLZRH-UHFFFAOYSA-N 0.000 claims 2
KNBHJJWOMHZEDQ-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCC(CC1)N1CCN(CC1)C)SC(C(=O)N)C1=CC=CC=C1 KNBHJJWOMHZEDQ-UHFFFAOYSA-N 0.000 claims 2
DQOICBVYYITCQG-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[4-(dimethylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCC(CC1)N(C)C)SC(C(=O)N)C1=CC=CC=C1 DQOICBVYYITCQG-UHFFFAOYSA-N 0.000 claims 2
KGRZKCREFYCZIS-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[4-(pyrrolidin-1-ylmethyl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCC(CC1)CN1CCCC1)SC(C(=O)N)C1=CC=CC=C1 KGRZKCREFYCZIS-UHFFFAOYSA-N 0.000 claims 2
FTKCQZIZGOMSAJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[4-[(4-methylpiperazin-1-yl)methyl]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCC(CC1)CN1CCN(CC1)C)SC(C(=O)N)C1=CC=CC=C1 FTKCQZIZGOMSAJ-UHFFFAOYSA-N 0.000 claims 2
GPDJMEHJOIYQIE-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[[2-(1,3-dihydroxypropan-2-ylamino)-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NC(CO)CO)C)C#N)C1CC1)C#N)=O GPDJMEHJOIYQIE-UHFFFAOYSA-N 0.000 claims 2
WYWXZWWQTUQOHY-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N(C)CC(=O)N1CC(C1)O)SC(C(=O)N)C1=CC=CC=C1 WYWXZWWQTUQOHY-UHFFFAOYSA-N 0.000 claims 2
LLVIJRJBWSAQNJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethoxy-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1OCC)C#N)N1CCN(CCC1)CCO)SC(C(=O)N)C1=CC=CC=C1 LLVIJRJBWSAQNJ-UHFFFAOYSA-N 0.000 claims 2
ORMVGEMLQLEGQS-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethoxy-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanylpropanamide Chemical compound C(#N)C=1C(=NC(=C(C=1OCC)C#N)N1CCN(CCC1)CCO)SC(C(=O)N)C ORMVGEMLQLEGQS-UHFFFAOYSA-N 0.000 claims 2
MPBQEERZVDUNNN-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(1-oxa-7-azaspiro[3.4]octan-7-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC2(CCO2)CC1)SC(C(=O)N)C1=CC=CC=C1 MPBQEERZVDUNNN-UHFFFAOYSA-N 0.000 claims 2
PRTNICOWHDVOMU-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC2=C(CC1)NN=N2)SC(C(=O)N)C1=CC=CC=C1 PRTNICOWHDVOMU-UHFFFAOYSA-N 0.000 claims 2
GJXGSRAPRAPLIX-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(2-methyl-2,8-diazaspiro[4.5]decan-8-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC2(CCN(C2)C)CC1)SC(C(=O)N)C1=CC=CC=C1 GJXGSRAPRAPLIX-UHFFFAOYSA-N 0.000 claims 2
DPLBLXGKZFRVOF-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(2-methyl-2,9-diazaspiro[5.5]undecan-9-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC2(CCCN(C2)C)CC1)SC(C(=O)N)C1=CC=CC=C1 DPLBLXGKZFRVOF-UHFFFAOYSA-N 0.000 claims 2
LCVVLDODJWARPO-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(2-morpholin-4-ylethylsulfanyl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)SCCN1CCOCC1)SC(C(=O)N)C1=CC=CC=C1 LCVVLDODJWARPO-UHFFFAOYSA-N 0.000 claims 2
KXVNYMOJYHKQRG-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(2-oxa-7-azaspiro[3.4]octan-7-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC2(COC2)CC1)SC(C(=O)N)C1=CC=CC=C1 KXVNYMOJYHKQRG-UHFFFAOYSA-N 0.000 claims 2
OUSMOLFOVYHQSJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-8-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC2(CNC(O2)=O)CC1)SC(C(=O)N)C1=CC=CC=C1 OUSMOLFOVYHQSJ-UHFFFAOYSA-N 0.000 claims 2
FFMZQDFWORDQBK-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(2-oxo-3-oxa-1,8-diazaspiro[4.5]decan-8-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC2(COC(N2)=O)CC1)SC(C(=O)N)C1=CC=CC=C1 FFMZQDFWORDQBK-UHFFFAOYSA-N 0.000 claims 2
UVYKEQNHOAEAFR-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(3-hydroxyazetidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(C1)O)SC(C(=O)N)C1=CC=CC=C1 UVYKEQNHOAEAFR-UHFFFAOYSA-N 0.000 claims 2
JXAUMWOTJFLYOC-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(3-methoxyazetidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(C1)OC)SC(C(=O)N)C1=CC=CC=C1 JXAUMWOTJFLYOC-UHFFFAOYSA-N 0.000 claims 2
MLKKPDGYCFASPL-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(3-oxopiperazin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(NCC1)=O)SC(C(=O)N)C1=CC=CC=C1 MLKKPDGYCFASPL-UHFFFAOYSA-N 0.000 claims 2
AVLOZCTUBSLSSQ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-ethyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CC)SC(C(=O)N)C1=CC=CC=C1 AVLOZCTUBSLSSQ-UHFFFAOYSA-N 0.000 claims 2
AAPJDNZBMDEKFD-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-ethylpiperazin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC)SC(C(=O)N)C1=CC=CC=C1 AAPJDNZBMDEKFD-UHFFFAOYSA-N 0.000 claims 2
MZWZOPMPMLVLSG-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-hydroxypiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)O)SC(C(=O)N)C1=CC=CC=C1 MZWZOPMPMLVLSG-UHFFFAOYSA-N 0.000 claims 2
INRBWUZLUYKOMW-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-imidazol-1-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1(C=NC=C1)C1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N INRBWUZLUYKOMW-UHFFFAOYSA-N 0.000 claims 2
CJPHXICXEMPGBK-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-(2,5-difluoropyridin-4-yl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)C)SC(C(=O)N)C1=CC(=NC=C1F)F CJPHXICXEMPGBK-UHFFFAOYSA-N 0.000 claims 2
ITJZKPALGDQSHW-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-(3-pyrrolidin-1-ylphenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)C)SC(C(=O)N)C1=CC(=CC=C1)N1CCCC1 ITJZKPALGDQSHW-UHFFFAOYSA-N 0.000 claims 2
FNVUXBZITHSRAB-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-[3-(trifluoromethyl)phenyl]acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)C)SC(C(=O)N)C1=CC(=CC=C1)C(F)(F)F FNVUXBZITHSRAB-UHFFFAOYSA-N 0.000 claims 2
OGKOHDZLDNFFAB-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-[4-(trifluoromethyl)phenyl]acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)C)SC(C(=O)N)C1=CC=C(C=C1)C(F)(F)F OGKOHDZLDNFFAB-UHFFFAOYSA-N 0.000 claims 2
XRKVILGXGOHWOA-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-methyl-3-oxopiperazin-1-yl)pyridin-2-yl]sulfanyl-2-pyridin-4-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(N(CC1)C)=O)SC(C(=O)N)C1=CC=NC=C1 XRKVILGXGOHWOA-UHFFFAOYSA-N 0.000 claims 2
AWDGEAGAQJZCNC-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-methyl-5-oxo-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(C(CC1)=O)C)SC(C(=O)N)C1=CC=CC=C1 AWDGEAGAQJZCNC-UHFFFAOYSA-N 0.000 claims 2
WHHWWBOLJJWTFW-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-morpholin-4-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1CCOCC1)SC(C(=O)N)C1=CC=CC=C1 WHHWWBOLJJWTFW-UHFFFAOYSA-N 0.000 claims 2
ZSYCORUQBBRZST-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-oxopiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)=O)SC(C(=O)N)C1=CC=CC=C1 ZSYCORUQBBRZST-UHFFFAOYSA-N 0.000 claims 2
SHZQMUGRDNKXPI-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-piperidin-4-ylpiperazin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)C1CCNCC1)SC(C(=O)N)C1=CC=CC=C1 SHZQMUGRDNKXPI-UHFFFAOYSA-N 0.000 claims 2
SBQYYTLFKRYESN-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-piperidin-4-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1(CCC(CC1)C1CCNCC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N SBQYYTLFKRYESN-UHFFFAOYSA-N 0.000 claims 2
ADKADAJBRJLLDR-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-propyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CCC)SC(C(=O)N)C1=CC=CC=C1 ADKADAJBRJLLDR-UHFFFAOYSA-N 0.000 claims 2
BXSOWNMNUBXYQU-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-propylpiperazin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CCC)SC(C(=O)N)C1=CC=CC=C1 BXSOWNMNUBXYQU-UHFFFAOYSA-N 0.000 claims 2
XYFVYDXBONPTKL-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-propylsulfonylpiperazin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)S(=O)(=O)CCC)SC(C(=O)N)C1=CC=CC=C1 XYFVYDXBONPTKL-UHFFFAOYSA-N 0.000 claims 2
HRPNGMXDWIEOMY-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-pyrrolidin-1-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1CCCC1)SC(C(=O)N)C1=CC=C(C=C1)F HRPNGMXDWIEOMY-UHFFFAOYSA-N 0.000 claims 2
XBGYNCRALWAEIG-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-pyrrolidin-1-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1CCCC1)SC(C(=O)N)C1=CC=CC=C1 XBGYNCRALWAEIG-UHFFFAOYSA-N 0.000 claims 2
MSLAJOMOZIQQLT-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-pyrrolidin-3-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)C1CNCC1)SC(C(=O)N)C1=CC=CC=C1 MSLAJOMOZIQQLT-UHFFFAOYSA-N 0.000 claims 2
NKZHWEUPJPIVQG-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(5-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCNC(CC1)C)SC(C(=O)N)C1=CC=CC=C1 NKZHWEUPJPIVQG-UHFFFAOYSA-N 0.000 claims 2
OTYYPWVAZKWPHH-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C2CN(C(C1)C2)C)SC(C(=O)N)C1=CC=CC=C1 OTYYPWVAZKWPHH-UHFFFAOYSA-N 0.000 claims 2
DYRMDGWLQARAHJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(5-oxo-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCNC(CC1)=O)SC(C(=O)N)C1=CC=CC=C1 DYRMDGWLQARAHJ-UHFFFAOYSA-N 0.000 claims 2
LEXIGEPZZLZYMJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(6-fluoro-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCNCC(C1)F)SC(C(=O)N)C1=CC=CC=C1 LEXIGEPZZLZYMJ-UHFFFAOYSA-N 0.000 claims 2
KYCSIHTYWHWBLQ-QRIPLOBPSA-N 2-[3,5-dicyano-4-ethyl-6-[(3R)-3-(methylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H](CCC1)NC)SC(C(=O)N)C1=CC=CC=C1 KYCSIHTYWHWBLQ-QRIPLOBPSA-N 0.000 claims 2
KYCSIHTYWHWBLQ-DJZRFWRSSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-(methylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CCC1)NC)SC(C(=O)N)C1=CC=CC=C1 KYCSIHTYWHWBLQ-DJZRFWRSSA-N 0.000 claims 2
KUCBWFLVTKEBHS-LBOXEOMUSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-(oxetan-3-ylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CCC1)NC1COC1)SC(C(=O)N)C1=CC=CC=C1 KUCBWFLVTKEBHS-LBOXEOMUSA-N 0.000 claims 2
YPBGXKXOWKRFMU-PBVYKCSPSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-[(2-hydroxy-2-methylpropyl)amino]pyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)NCC(C)(C)O)SC(C(=O)N)C1=CC=CC=C1 YPBGXKXOWKRFMU-PBVYKCSPSA-N 0.000 claims 2
FXMCLLNYHJNMHU-FAQQKDIKSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-(2,3-difluorophenyl)acetamide Chemical compound CCC1=C(C#N)C(SC(C(N)=O)C2=C(F)C(F)=CC=C2)=NC(N2CC[C@H](O)C2)=C1C#N FXMCLLNYHJNMHU-FAQQKDIKSA-N 0.000 claims 2
LACBFVVSYQHECW-RSXQAXDFSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-(2,4-difluorophenyl)acetamide Chemical compound CCC1=C(C#N)C(SC(C(N)=O)C2=C(F)C=C(F)C=C2)=NC(N2CC[C@H](O)C2)=C1C#N LACBFVVSYQHECW-RSXQAXDFSA-N 0.000 claims 2
AJRSRLUTGVVUQN-FAQQKDIKSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-(2,6-difluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)SC(C(=O)N)C1=C(C=CC=C1F)F AJRSRLUTGVVUQN-FAQQKDIKSA-N 0.000 claims 2
SGKXYWJWSIWWEY-RSXQAXDFSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-(2-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)SC(C(=O)N)C1=C(C=CC=C1)F SGKXYWJWSIWWEY-RSXQAXDFSA-N 0.000 claims 2
OGVQOTBFEPJZRB-OOJLDXBWSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-(3-dimethylphosphorylphenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)SC(C(=O)N)C1=CC(=CC=C1)P(=O)(C)C OGVQOTBFEPJZRB-OOJLDXBWSA-N 0.000 claims 2
HLAISKDDYRGCNF-PIVQAISJSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound CCC1=C(C#N)C(SC(C(N)=O)C2=CC=C(F)C=C2)=NC(N2CC[C@H](O)C2)=C1C#N HLAISKDDYRGCNF-PIVQAISJSA-N 0.000 claims 2
ZLNMIQXSXVLFRG-WHUIICBVSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-pyridin-2-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)SC(C(=O)N)C1=NC=CC=C1 ZLNMIQXSXVLFRG-WHUIICBVSA-N 0.000 claims 2
IVLHXSIQOYWYEZ-CWQZNGJJSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-pyridin-3-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)SC(C(=O)N)C=1C=NC=CC=1 IVLHXSIQOYWYEZ-CWQZNGJJSA-N 0.000 claims 2
BZTZVKGCRZLLBX-CWQZNGJJSA-N 2-[3,5-dicyano-4-ethyl-6-[(4S)-4-hydroxy-1,2-oxazolidin-2-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1OC[C@H](C1)O)SC(C(=O)N)C1=CC=CC=C1 BZTZVKGCRZLLBX-CWQZNGJJSA-N 0.000 claims 2
BINSAYRDVGYJAZ-DCFJUCRTSA-N 2-[3,5-dicyano-4-ethyl-6-[(5S,6S)-6-hydroxy-1-methylsulfonyl-1,8-diazaspiro[4.5]decan-8-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H]([C@]2(CCCN2S(=O)(=O)C)CC1)O)SC(C(=O)N)C1=CC=CC=C1 BINSAYRDVGYJAZ-DCFJUCRTSA-N 0.000 claims 2
XXLDDFUGJHQDRO-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[1H-imidazol-2-ylmethyl(methyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1C(=NC=C1)CN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C XXLDDFUGJHQDRO-UHFFFAOYSA-N 0.000 claims 2
AEGNVXPUMDPJDQ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[1H-imidazol-5-ylmethyl(methyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1C=NC=C1CN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C AEGNVXPUMDPJDQ-UHFFFAOYSA-N 0.000 claims 2
JSOIARXDGFXKJJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[2-(2-fluoroethylamino)ethyl-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCNCCF)SC(C(=O)N)C1=CC=CC=C1 JSOIARXDGFXKJJ-UHFFFAOYSA-N 0.000 claims 2
CFWYACPXXZHDAI-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[2-(2-methoxyethylamino)ethyl-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCNCCOC)SC(C(=O)N)C1=CC=CC=C1 CFWYACPXXZHDAI-UHFFFAOYSA-N 0.000 claims 2
TVKFTXSUHZNTFK-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[2-(ethylamino)ethyl-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCNCC)SC(C(=O)N)C1=CC=CC=C1 TVKFTXSUHZNTFK-UHFFFAOYSA-N 0.000 claims 2
GKIMTORUWNIQRW-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[2-(methylaminomethyl)morpholin-4-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(OCC1)CNC)SC(C(=O)N)C1=CC=CC=C1 GKIMTORUWNIQRW-UHFFFAOYSA-N 0.000 claims 2
GWIYLVSLHAAZEW-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[2-(pyrrolidin-1-ylmethyl)morpholin-4-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(OCC1)CN1CCCC1)SC(C(=O)N)C1=CC=CC=C1 GWIYLVSLHAAZEW-UHFFFAOYSA-N 0.000 claims 2
LBMSTGPCJAOOAZ-ZZWBGTBQSA-N 2-[3,5-dicyano-4-ethyl-6-[2-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]ethyl-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN1[C@H](CCC1)CO)SC(C(=O)N)C1=CC=CC=C1 LBMSTGPCJAOOAZ-ZZWBGTBQSA-N 0.000 claims 2
LBMSTGPCJAOOAZ-HXBUSHRASA-N 2-[3,5-dicyano-4-ethyl-6-[2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]ethyl-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN1[C@@H](CCC1)CO)SC(C(=O)N)C1=CC=CC=C1 LBMSTGPCJAOOAZ-HXBUSHRASA-N 0.000 claims 2
ZIGAZNXZOLPFOS-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[2-[ethyl(methyl)amino]ethyl-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN(C)CC)SC(C(=O)N)C1=CC=CC=C1 ZIGAZNXZOLPFOS-UHFFFAOYSA-N 0.000 claims 2
XOYGSTAJAGOUHB-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[2-hydroxyethyl(methyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCO)SC(C(=O)N)C1=CC=CC=C1 XOYGSTAJAGOUHB-UHFFFAOYSA-N 0.000 claims 2
WUIIBRJZPQPKLB-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[2-methoxyethyl(methyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCOC)SC(C(=O)N)C1=CC=CC=C1 WUIIBRJZPQPKLB-UHFFFAOYSA-N 0.000 claims 2
HIQJFAUXGXYIDL-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[3-(hydroxymethyl)azetidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(C1)CO)SC(C(=O)N)C1=CC=CC=C1 HIQJFAUXGXYIDL-UHFFFAOYSA-N 0.000 claims 2
TXXSJMRWNWLMIM-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[3-(methylamino)pyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(CC1)NC)SC(C(=O)N)C1=CC=CC=C1 TXXSJMRWNWLMIM-UHFFFAOYSA-N 0.000 claims 2
NJVYJNIZUSABLP-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[3-(methylaminomethyl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(CCC1)CNC)SC(C(=O)N)C1=CC=CC=C1 NJVYJNIZUSABLP-UHFFFAOYSA-N 0.000 claims 2
XHHMGEACDFDLES-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[3-[(2-hydroxyacetyl)amino]azetidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1CC(C1)NC(CO)=O)C#N)CC)C#N)=O XHHMGEACDFDLES-UHFFFAOYSA-N 0.000 claims 2
QPEAFCKDCCOTNE-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[3-fluoro-4-(methylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(C(CC1)NC)F)SC(C(=O)N)C1=CC=CC=C1 QPEAFCKDCCOTNE-UHFFFAOYSA-N 0.000 claims 2
KIZVFGMDTAUJBR-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1,2-oxazol-3-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC1=NOC=C1)SC(C(=O)N)C1=CC=CC=C1 KIZVFGMDTAUJBR-UHFFFAOYSA-N 0.000 claims 2
RPQOZEOVRRPDEL-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1,2-oxazol-4-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC=1C=NOC=1)SC(C(=O)N)C1=CC=CC=C1 RPQOZEOVRRPDEL-UHFFFAOYSA-N 0.000 claims 2
RKZBTUCLUHINBO-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1,2-thiazol-4-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC=1C=NSC=1)SC(C(=O)N)C1=CC=CC=C1 RKZBTUCLUHINBO-UHFFFAOYSA-N 0.000 claims 2
IQOASBFTNDTNSC-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1,3-oxazol-2-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC=1OC=CN=1)SC(C(=O)N)C1=CC=CC=C1 IQOASBFTNDTNSC-UHFFFAOYSA-N 0.000 claims 2
DSAZSJIGPVLSCJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1,3-oxazol-5-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC1=CN=CO1)SC(C(=O)N)C1=CC=CC=C1 DSAZSJIGPVLSCJ-UHFFFAOYSA-N 0.000 claims 2
PMIYBZXAPUTCHR-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1,3-thiazol-5-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC1=CN=CS1)SC(C(=O)N)C1=CC=CC=C1 PMIYBZXAPUTCHR-UHFFFAOYSA-N 0.000 claims 2
RNDSFIUHOPIRNK-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1-hydroxy-2-methylpropan-2-yl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)C(CO)(C)C)SC(C(=O)N)C1=CC=C(C=C1)F RNDSFIUHOPIRNK-UHFFFAOYSA-N 0.000 claims 2
XTVNNJYGSVPNGZ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1-hydroxy-2-methylpropan-2-yl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)C(CO)(C)C)SC(C(=O)N)C1=CC=CC=C1 XTVNNJYGSVPNGZ-UHFFFAOYSA-N 0.000 claims 2
BTKQIZKHKDPADB-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1H-imidazol-2-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1C(=NC=C1)CN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N BTKQIZKHKDPADB-UHFFFAOYSA-N 0.000 claims 2
OMVYNAREKXDGRR-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1H-imidazol-5-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1C=NC=C1CN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N OMVYNAREKXDGRR-UHFFFAOYSA-N 0.000 claims 2
GFFDCWJMRYYKPH-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1N=CC(=C1)CN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N GFFDCWJMRYYKPH-UHFFFAOYSA-N 0.000 claims 2
CLTWRYNIRGEYRE-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1H-pyrrol-2-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1C(=CC=C1)CN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N CLTWRYNIRGEYRE-UHFFFAOYSA-N 0.000 claims 2
PEBIUNFFJUYUEC-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1H-pyrrol-3-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1C=C(C=C1)CN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N PEBIUNFFJUYUEC-UHFFFAOYSA-N 0.000 claims 2
XHCSPVVTYDYEFH-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxy-2-methylpropyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CC(C)(C)O)SC(C(=O)N)C1=CC=CC=C1 XHCSPVVTYDYEFH-UHFFFAOYSA-N 0.000 claims 2
QXYIXZOLKPEBJL-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxyethoxy)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)OCCO)SC(C(=O)N)C1=CC=CC=C1 QXYIXZOLKPEBJL-UHFFFAOYSA-N 0.000 claims 2
IHXXDZHXEBKTKE-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CCO)SC(C(=O)N)C1=CC=CC=C1 IHXXDZHXEBKTKE-UHFFFAOYSA-N 0.000 claims 2
HBKDLBCIDCHZSV-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxyethyl)-3-oxopiperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(N(CC1)CCO)=O)SC(C(=O)N)C1=CC=CC=C1 HBKDLBCIDCHZSV-UHFFFAOYSA-N 0.000 claims 2
DHHQTWDRYOCVNT-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxyethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CCO)SC(C(=O)N)C1=CC=CC=C1 DHHQTWDRYOCVNT-UHFFFAOYSA-N 0.000 claims 2
BFMFJWREJHGPKE-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxyethylamino)-4-(hydroxymethyl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)(CO)NCCO)SC(C(=O)N)C1=CC=CC=C1 BFMFJWREJHGPKE-UHFFFAOYSA-N 0.000 claims 2
NTPKLKPQZNOIJT-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxypropyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CC(C)O)SC(C(=O)N)C1=CC=CC=C1 NTPKLKPQZNOIJT-UHFFFAOYSA-N 0.000 claims 2
OQLDOBSEBOWDCU-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-methoxyethyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CCOC)SC(C(=O)N)C1=CC=CC=C1 OQLDOBSEBOWDCU-UHFFFAOYSA-N 0.000 claims 2
XICDBICWYVZRIF-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-methoxyethylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCCOC)SC(C(=O)N)C1=CC=CC=C1 XICDBICWYVZRIF-UHFFFAOYSA-N 0.000 claims 2
SEKRLNNIWWYPDC-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-oxoimidazolidin-1-yl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1C(NCC1)=O)SC(C(=O)N)C1=CC=CC=C1 SEKRLNNIWWYPDC-UHFFFAOYSA-N 0.000 claims 2
XVIJFPOMYTUTOS-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CCN1CCCC1)SC(C(=O)N)C1=CC=CC=C1 XVIJFPOMYTUTOS-UHFFFAOYSA-N 0.000 claims 2
HMMVROADJJIGTL-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(3-methoxyazetidin-1-yl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1CC(C1)OC)SC(C(=O)N)C1=CC=C(C=C1)F HMMVROADJJIGTL-UHFFFAOYSA-N 0.000 claims 2
FHNBIFLOYRQNAW-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(3-methoxyazetidin-1-yl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1CC(C1)OC)SC(C(=O)N)C1=CC=CC=C1 FHNBIFLOYRQNAW-UHFFFAOYSA-N 0.000 claims 2
ZZGFAGXPUQJHON-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1CCN(CC1)C)SC(C(=O)N)C1=CC=CC=C1 ZZGFAGXPUQJHON-UHFFFAOYSA-N 0.000 claims 2
ZYLLCQFEFGXLIG-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(furan-3-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC1=COC=C1)SC(C(=O)N)C1=CC=CC=C1 ZYLLCQFEFGXLIG-UHFFFAOYSA-N 0.000 claims 2
KBKLXIFMIVJIII-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(methylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NC)SC(C(=O)N)C1=CC=C(C=C1)F KBKLXIFMIVJIII-UHFFFAOYSA-N 0.000 claims 2
UFTKGXPMSNOOTN-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(methylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NC)SC(C(=O)N)C1=CC=CC=C1 UFTKGXPMSNOOTN-UHFFFAOYSA-N 0.000 claims 2
GBWTUGZWJNAVLE-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(oxetan-3-yloxy)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)OC1COC1)SC(C(=O)N)C1=CC=CC=C1 GBWTUGZWJNAVLE-UHFFFAOYSA-N 0.000 claims 2
HOIWOTUORCYCGG-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(pyridin-4-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC1=CC=NC=C1)SC(C(=O)N)C1=CC=CC=C1 HOIWOTUORCYCGG-UHFFFAOYSA-N 0.000 claims 2
XXDQNQJEPNVGBO-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(pyrrolidin-1-ylmethyl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)CN1CCCC1)SC(C(=O)N)C1=CC=CC=C1 XXDQNQJEPNVGBO-UHFFFAOYSA-N 0.000 claims 2
IVDBFJXQDPWQRW-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(2-hydroxy-2-methylpropyl)-methylamino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)CC(C)(C)O)SC(C(=O)N)C1=CC=CC=C1 IVDBFJXQDPWQRW-UHFFFAOYSA-N 0.000 claims 2
SCMIHGKFSROBLR-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(2-hydroxy-2-methylpropyl)amino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCC(C)(C)O)SC(C(=O)N)C1=CC=C(C=C1)F SCMIHGKFSROBLR-UHFFFAOYSA-N 0.000 claims 2
YMKSTCPMALFTRO-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(2-hydroxyacetyl)amino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1CCC(CC1)NC(CO)=O)C#N)CC)C#N)=O YMKSTCPMALFTRO-UHFFFAOYSA-N 0.000 claims 2
AQAGUJBKESAHAB-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(2-methoxy-2-methylpropyl)-methylamino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)CC(C)(C)OC)SC(C(=O)N)C1=CC=CC=C1 AQAGUJBKESAHAB-UHFFFAOYSA-N 0.000 claims 2
MTIHTGQEJCRVHD-CGHJUBPDSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1[C@H](CCC1)CO)SC(C(=O)N)C1=CC=CC=C1 MTIHTGQEJCRVHD-CGHJUBPDSA-N 0.000 claims 2
UEARZJBSXHFNRJ-QFADGXAASA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(2R)-2-methylpyrrolidin-1-yl]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1[C@@H](CCC1)C)SC(C(=O)N)C1=CC=CC=C1 UEARZJBSXHFNRJ-QFADGXAASA-N 0.000 claims 2
MTIHTGQEJCRVHD-QHELBMECSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1[C@@H](CCC1)CO)SC(C(=O)N)C1=CC=CC=C1 MTIHTGQEJCRVHD-QHELBMECSA-N 0.000 claims 2
UEARZJBSXHFNRJ-VEXWJQHLSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(2S)-2-methylpyrrolidin-1-yl]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1[C@H](CCC1)C)SC(C(=O)N)C1=CC=CC=C1 UEARZJBSXHFNRJ-VEXWJQHLSA-N 0.000 claims 2
IEGUDBMUKZBOIA-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(3-methyloxetan-3-yl)methylamino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCC1(COC1)C)SC(C(=O)N)C1=CC=CC=C1 IEGUDBMUKZBOIA-UHFFFAOYSA-N 0.000 claims 2
UPIDRZFDVJKDAR-FKSKYRLFSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(3R)-3-fluoropyrrolidin-1-yl]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1C[C@@H](CC1)F)SC(C(=O)N)C1=CC=CC=C1 UPIDRZFDVJKDAR-FKSKYRLFSA-N 0.000 claims 2
UPIDRZFDVJKDAR-XNUZUHMRSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(3S)-3-fluoropyrrolidin-1-yl]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1C[C@H](CC1)F)SC(C(=O)N)C1=CC=CC=C1 UPIDRZFDVJKDAR-XNUZUHMRSA-N 0.000 claims 2
IQPDOUJLTIQQNF-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(4-fluorophenyl)methylamino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCC1=CC=C(C=C1)F)SC(C(=O)N)C1=CC=CC=C1 IQPDOUJLTIQQNF-UHFFFAOYSA-N 0.000 claims 2
NIWGXXSRIJYYQK-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(6-methoxypyridin-2-yl)methylamino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCC1=NC(=CC=C1)OC)SC(C(=O)N)C1=CC=CC=C1 NIWGXXSRIJYYQK-UHFFFAOYSA-N 0.000 claims 2
JZLXWXHKODYZML-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(6-methoxypyridin-3-yl)methylamino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCC=1C=NC(=CC=1)OC)SC(C(=O)N)C1=CC=CC=C1 JZLXWXHKODYZML-UHFFFAOYSA-N 0.000 claims 2
RKMJIGDAMDXJMQ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[1-(2-hydroxyethyl)piperidin-4-yl]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)C1CCN(CC1)CCO)SC(C(=O)N)C1=CC=CC=C1 RKMJIGDAMDXJMQ-UHFFFAOYSA-N 0.000 claims 2
SZJGIJPYCAHINT-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[2-hydroxyethyl(methyl)amino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)CCO)SC(C(=O)N)C1=CC=CC=C1 SZJGIJPYCAHINT-UHFFFAOYSA-N 0.000 claims 2
MZUYDNIDARRTKI-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[ethyl(methyl)amino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)CC)SC(C(=O)N)C1=CC=CC=C1 MZUYDNIDARRTKI-UHFFFAOYSA-N 0.000 claims 2
XZKAHJSGNPZLNY-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-hydroxy-4-(hydroxymethyl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)(CO)O)SC(C(=O)N)C1=CC=CC=C1 XZKAHJSGNPZLNY-UHFFFAOYSA-N 0.000 claims 2
YVMIQLHNHFIPJM-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-(2-hydroxyethylamino)-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NCCO)C)C#N)CC)C#N)=O YVMIQLHNHFIPJM-UHFFFAOYSA-N 0.000 claims 2
CSFVKQAXFPKGMN-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1CC(C1)O)SC(C(=O)N)C1=CC=CC=C1 CSFVKQAXFPKGMN-UHFFFAOYSA-N 0.000 claims 2
FHUNQIPUXZVGHZ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-(3-hydroxypropylamino)-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NCCCO)C)C#N)CC)C#N)=O FHUNQIPUXZVGHZ-UHFFFAOYSA-N 0.000 claims 2
PHJQREKPOYTERI-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-(4-hydroxypiperidin-1-yl)-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1CCC(CC1)O)SC(C(=O)N)C1=CC=CC=C1 PHJQREKPOYTERI-UHFFFAOYSA-N 0.000 claims 2
MMXJOQNWUOEIHO-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-(hydroxyamino)-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NO)C)C#N)CC)C#N)=O MMXJOQNWUOEIHO-UHFFFAOYSA-N 0.000 claims 2
DOEGYPGFKNQPFF-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-(methoxyamino)-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NOC)C)C#N)CC)C#N)=O DOEGYPGFKNQPFF-UHFFFAOYSA-N 0.000 claims 2
ZIAOVEGAKJALAA-PLEWWHCXSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(2R)-2-(hydroxymethyl)morpholin-4-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@@H](OCC1)CO)SC(C(=O)N)C1=CC=CC=C1 ZIAOVEGAKJALAA-PLEWWHCXSA-N 0.000 claims 2
ZIAOVEGAKJALAA-LBOXEOMUSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(2S)-2-(hydroxymethyl)morpholin-4-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@H](OCC1)CO)SC(C(=O)N)C1=CC=CC=C1 ZIAOVEGAKJALAA-LBOXEOMUSA-N 0.000 claims 2
ZAPHVOWJURLYDS-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3-hydroxy-2,2-dimethylpropyl)-methylamino]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)N(C)CC(CO)(C)C)C)C#N)CC)C#N)=O ZAPHVOWJURLYDS-UHFFFAOYSA-N 0.000 claims 2
SXIDJQRZNJGGHF-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3-hydroxy-2,2-dimethylpropyl)amino]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NCC(CO)(C)C)C)C#N)CC)C#N)=O SXIDJQRZNJGGHF-UHFFFAOYSA-N 0.000 claims 2
DXRYEUXKCNACDD-XESZBRCGSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3R)-3-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@@H](CC1)CO)SC(C(=O)N)C1=CC=CC=C1 DXRYEUXKCNACDD-XESZBRCGSA-N 0.000 claims 2
FWMQSCDFVUDXPV-UJONTBEJSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3R)-3-hydroxypyrrolidin-1-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@@H](CC1)O)SC(C(=O)N)C1=CC=CC=C1 FWMQSCDFVUDXPV-UJONTBEJSA-N 0.000 claims 2
SYVCBYSQKVUBDF-FLWMDHGKSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3R,4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@@H]([C@H](C1)CO)O)SC(C(=O)N)C1=CC=CC=C1 SYVCBYSQKVUBDF-FLWMDHGKSA-N 0.000 claims 2
SYVCBYSQKVUBDF-MZRGNRRKSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3R,4S)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@@H]([C@@H](C1)CO)O)SC(C(=O)N)C1=CC=CC=C1 SYVCBYSQKVUBDF-MZRGNRRKSA-N 0.000 claims 2
DXRYEUXKCNACDD-CISYCMJJSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3S)-3-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@H](CC1)CO)SC(C(=O)N)C1=CC=CC=C1 DXRYEUXKCNACDD-CISYCMJJSA-N 0.000 claims 2
FWMQSCDFVUDXPV-BJQOMGFOSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3S)-3-hydroxypyrrolidin-1-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@H](CC1)O)SC(C(=O)N)C1=CC=CC=C1 FWMQSCDFVUDXPV-BJQOMGFOSA-N 0.000 claims 2
SYVCBYSQKVUBDF-LMYOSFIVSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3S,4S)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@H]([C@@H](C1)CO)O)SC(C(=O)N)C1=CC=CC=C1 SYVCBYSQKVUBDF-LMYOSFIVSA-N 0.000 claims 2
REKRNEBMFQNOPB-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[2-hydroxyethyl(methyl)amino]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)N(C)CCO)C)C#N)CC)C#N)=O REKRNEBMFQNOPB-UHFFFAOYSA-N 0.000 claims 2
RPHPDPXBKSZFBC-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[3-hydroxypropyl(methyl)amino]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)N(C)CCCO)C)C#N)CC)C#N)=O RPHPDPXBKSZFBC-UHFFFAOYSA-N 0.000 claims 2
KXCSCVBNPHMMHE-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[[1-(hydroxymethyl)cyclopropyl]methyl-methylamino]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)N(C)CC1(CC1)CO)C)C#N)CC)C#N)=O KXCSCVBNPHMMHE-UHFFFAOYSA-N 0.000 claims 2
WAVPTLOLGBOKPG-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[[1-(hydroxymethyl)cyclopropyl]methylamino]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NCC1(CC1)CO)C)C#N)CC)C#N)=O WAVPTLOLGBOKPG-UHFFFAOYSA-N 0.000 claims 2
VLTAETQBPNTGJB-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[[3-(hydroxymethyl)oxetan-3-yl]amino]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NC1(COC1)CO)C)C#N)CC)C#N)=O VLTAETQBPNTGJB-UHFFFAOYSA-N 0.000 claims 2
PXDGHDPYXXCUOJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl(1H-1,2,4-triazol-5-ylmethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N=1N=C(NC=1)CN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C PXDGHDPYXXCUOJ-UHFFFAOYSA-N 0.000 claims 2
XAGXVCSOGVMAKK-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl(1H-pyrazol-5-ylmethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1N=C(C=C1)CN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C XAGXVCSOGVMAKK-UHFFFAOYSA-N 0.000 claims 2
QWCYDTNDPXJDQJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl(2-morpholin-4-ylethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCN1CCOCC1)C)SC(C(=O)N)C1=CC=CC=C1 QWCYDTNDPXJDQJ-UHFFFAOYSA-N 0.000 claims 2
YOLKANZDCJBWCN-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl(2-piperazin-1-ylethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCN1CCNCC1)C)SC(C(=O)N)C1=CC=CC=C1 YOLKANZDCJBWCN-UHFFFAOYSA-N 0.000 claims 2
WSRKQFVILNOYDU-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl(2-piperidin-1-ylethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCN1CCCCC1)C)SC(C(=O)N)C1=CC=CC=C1 WSRKQFVILNOYDU-UHFFFAOYSA-N 0.000 claims 2
JRVWPOXQXJNLHI-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl(2-pyrrolidin-1-ylethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCN1CCCC1)C)SC(C(=O)N)C1=CC=CC=C1 JRVWPOXQXJNLHI-UHFFFAOYSA-N 0.000 claims 2
BXKMICZSTUMFTI-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-(1-methylpyrrolidin-3-yl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C1CN(CC1)C)C)SC(C(=O)N)C1=CC=CC=C1 BXKMICZSTUMFTI-UHFFFAOYSA-N 0.000 claims 2
AZCDJBJGTWPUEH-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-(2-morpholin-4-yl-2-oxoethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CC(=O)N1CCOCC1)C)SC(C(=O)N)C1=CC=CC=C1 AZCDJBJGTWPUEH-UHFFFAOYSA-N 0.000 claims 2
QHGZKWOEXDKSNP-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-(2-oxo-2-piperazin-1-ylethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CC(N1CCNCC1)=O)C)SC(C(=O)N)C1=CC=CC=C1 QHGZKWOEXDKSNP-UHFFFAOYSA-N 0.000 claims 2
GOTMZVBKIJOKNM-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-(2-oxo-2-pyrrolidin-1-ylethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CC(N1CCCC1)=O)C)SC(C(=O)N)C1=CC=CC=C1 GOTMZVBKIJOKNM-UHFFFAOYSA-N 0.000 claims 2
YAGFDFMTNLEVAD-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-[2-(1,2,4-triazol-4-yl)ethyl]amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N=1N=CN(C=1)CCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C YAGFDFMTNLEVAD-UHFFFAOYSA-N 0.000 claims 2
FLMFAKLJVLHPCJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-[2-(methylamino)ethyl]amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCNC)C)SC(C(=O)N)C1=CC=CC=C1 FLMFAKLJVLHPCJ-UHFFFAOYSA-N 0.000 claims 2
GYTNFNQZAZKEBM-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-[2-[(1-methylcyclopropyl)amino]ethyl]amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCNC1(CC1)C)C)SC(C(=O)N)C1=CC=CC=C1 GYTNFNQZAZKEBM-UHFFFAOYSA-N 0.000 claims 2
AFYYBIJBKDLIFQ-PLEWWHCXSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-[2-[(2R)-2-methylpyrrolidin-1-yl]ethyl]amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCN1[C@@H](CCC1)C)C)SC(C(=O)N)C1=CC=CC=C1 AFYYBIJBKDLIFQ-PLEWWHCXSA-N 0.000 claims 2
AFYYBIJBKDLIFQ-LBOXEOMUSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-[2-[(2S)-2-methylpyrrolidin-1-yl]ethyl]amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCN1[C@H](CCC1)C)C)SC(C(=O)N)C1=CC=CC=C1 AFYYBIJBKDLIFQ-LBOXEOMUSA-N 0.000 claims 2
XMAWVXNSOLWLDD-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-[2-oxo-2-[2-(1,2,4-triazol-4-yl)ethylamino]ethyl]amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N=1N=CN(C=1)CCNC(CN(C)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)=O XMAWVXNSOLWLDD-UHFFFAOYSA-N 0.000 claims 2
TYESDUSDOSXIOA-UHFFFAOYSA-N 2-[3,5-dicyano-6-(1,4-diazepan-1-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCNCCC1)SC(C(=O)N)C1=CC=CC=C1 TYESDUSDOSXIOA-UHFFFAOYSA-N 0.000 claims 2
XWKHPFHSUYTASB-UHFFFAOYSA-N 2-[3,5-dicyano-6-(1,7-diazaspiro[3.5]nonan-1-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC11CCNCC1)SC(C(=O)N)C1=CC=CC=C1 XWKHPFHSUYTASB-UHFFFAOYSA-N 0.000 claims 2
LEWPINXKUHMGEL-UHFFFAOYSA-N 2-[3,5-dicyano-6-(2,6-diazaspiro[3.4]octan-6-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC2(CNC2)CC1)SC(C(=O)N)C1=CC=CC=C1 LEWPINXKUHMGEL-UHFFFAOYSA-N 0.000 claims 2
JMLPWQOLWATUHA-UHFFFAOYSA-N 2-[3,5-dicyano-6-(2,7-diazaspiro[3.5]nonan-7-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC2(CNC2)CC1)SC(C(=O)N)C1=CC=CC=C1 JMLPWQOLWATUHA-UHFFFAOYSA-N 0.000 claims 2
BEBNLHNDQXVVCT-UHFFFAOYSA-N 2-[3,5-dicyano-6-(2,8-diazaspiro[4.5]decan-8-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC2(CCNC2)CC1)SC(C(=O)N)C1=CC=CC=C1 BEBNLHNDQXVVCT-UHFFFAOYSA-N 0.000 claims 2
PXUHGLRILYSXLC-UHFFFAOYSA-N 2-[3,5-dicyano-6-(2,9-diazaspiro[5.5]undecan-9-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC2(CCCNC2)CC1)SC(C(=O)N)C1=CC=CC=C1 PXUHGLRILYSXLC-UHFFFAOYSA-N 0.000 claims 2
XUKVOWURBPFJOR-UHFFFAOYSA-N 2-[3,5-dicyano-6-(3,4-dihydro-1H-2,7-naphthyridin-2-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC2=CN=CC=C2CC1)SC(C(=O)N)C1=CC=CC=C1 XUKVOWURBPFJOR-UHFFFAOYSA-N 0.000 claims 2
NDADFHCJBWQSAN-UHFFFAOYSA-N 2-[3,5-dicyano-6-(4,4-difluoropiperidin-1-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)(F)F)SC(C(=O)N)C1=CC=CC=C1 NDADFHCJBWQSAN-UHFFFAOYSA-N 0.000 claims 2
MOMXNTDAKQMDGL-UHFFFAOYSA-N 2-[3,5-dicyano-6-(4-cyanopiperidin-1-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)C#N)SC(C(=O)N)C1=CC=CC=C1 MOMXNTDAKQMDGL-UHFFFAOYSA-N 0.000 claims 2
ZOKFQKIHTSQWMB-UHFFFAOYSA-N 2-[3,5-dicyano-6-(4-methyl-1,4-diazepan-1-yl)-4-methylsulfanylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1SC)C#N)N1CCN(CCC1)C)SC(C(=O)N)C1=CC=CC=C1 ZOKFQKIHTSQWMB-UHFFFAOYSA-N 0.000 claims 2
VJZCIQKFGZRKOZ-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethoxypyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1OCC)C#N)N(C)C)SC(C(=O)N)C1=CC=CC=C1 VJZCIQKFGZRKOZ-UHFFFAOYSA-N 0.000 claims 2
DGPYYDAKNCUFTM-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-(3-dimethylphosphorylphenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=CC(=CC=C1)P(=O)(C)C DGPYYDAKNCUFTM-UHFFFAOYSA-N 0.000 claims 2
XJPACZHPKYWNAI-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=CC=C(C=C1)F XJPACZHPKYWNAI-UHFFFAOYSA-N 0.000 claims 2
JAOCSOYTIDHNNZ-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-(5-fluoropyridin-2-yl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=NC=C(C=C1)F JAOCSOYTIDHNNZ-UHFFFAOYSA-N 0.000 claims 2
RLKIRELOSIQUOZ-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-(5-methoxypyridin-2-yl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=NC=C(C=C1)OC RLKIRELOSIQUOZ-UHFFFAOYSA-N 0.000 claims 2
BKTPFLWAQPACLF-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-(5-methylpyridin-2-yl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=NC=C(C=C1)C BKTPFLWAQPACLF-UHFFFAOYSA-N 0.000 claims 2
PBCCXXFCZHRVEH-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-[3-[2-(dimethylamino)ethoxy]phenyl]acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=CC(=CC=C1)OCCN(C)C PBCCXXFCZHRVEH-UHFFFAOYSA-N 0.000 claims 2
XNLJPIURINSBAY-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-[4-(methylsulfamoyl)phenyl]acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=CC=C(C=C1)S(NC)(=O)=O XNLJPIURINSBAY-UHFFFAOYSA-N 0.000 claims 2
KIEQQZZDWUNUQK-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=CC=CC=C1 KIEQQZZDWUNUQK-UHFFFAOYSA-N 0.000 claims 2
PMUMTMWTHCXFJB-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-piperidin-4-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1CCNCC1 PMUMTMWTHCXFJB-UHFFFAOYSA-N 0.000 claims 2
CEFQBSLEFRRXOP-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-pyridin-4-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=CC=NC=C1 CEFQBSLEFRRXOP-UHFFFAOYSA-N 0.000 claims 2
PGEYCFMOSDKGRP-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-methoxypyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1OC)C#N)N(C)C)SC(C(=O)N)C1=CC=CC=C1 PGEYCFMOSDKGRP-UHFFFAOYSA-N 0.000 claims 2
AXKAVBGAZHPOHC-HWYAHNCWSA-N 2-[3,5-dicyano-6-[(2R)-2-(diethylaminomethyl)morpholin-4-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](OCC1)CN(CC)CC)SC(C(=O)N)C1=CC=CC=C1 AXKAVBGAZHPOHC-HWYAHNCWSA-N 0.000 claims 2
PDBFXYQPIAOBSW-HWYAHNCWSA-N 2-[3,5-dicyano-6-[(2R)-2-[(2,2-dimethylpropylamino)methyl]morpholin-4-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](OCC1)CNCC(C)(C)C)SC(C(=O)N)C1=CC=CC=C1 PDBFXYQPIAOBSW-HWYAHNCWSA-N 0.000 claims 2
PDBFXYQPIAOBSW-HSTJUUNISA-N 2-[3,5-dicyano-6-[(2S)-2-[(2,2-dimethylpropylamino)methyl]morpholin-4-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H](OCC1)CNCC(C)(C)C)SC(C(=O)N)C1=CC=CC=C1 PDBFXYQPIAOBSW-HSTJUUNISA-N 0.000 claims 2
UXBDLRYUGBZZNB-QRIPLOBPSA-N 2-[3,5-dicyano-6-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H](CC1)N(C)C)SC(C(=O)N)C1=CC=CC=C1 UXBDLRYUGBZZNB-QRIPLOBPSA-N 0.000 claims 2
AODJRWVDEBWQQH-BJQOMGFOSA-N 2-[3,5-dicyano-6-[(3S)-3-(2,2-difluoroethylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CCC1)NCC(F)F)SC(C(=O)N)C1=CC=CC=C1 AODJRWVDEBWQQH-BJQOMGFOSA-N 0.000 claims 2
GUZMORBPNRJGHC-HSTJUUNISA-N 2-[3,5-dicyano-6-[(3S)-3-(2,2-dimethylpropylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CCC1)NCC(C)(C)C)SC(C(=O)N)C1=CC=CC=C1 GUZMORBPNRJGHC-HSTJUUNISA-N 0.000 claims 2
XRDSGFIUOVUAFR-HXBUSHRASA-N 2-[3,5-dicyano-6-[(3S)-3-(cyclopropylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CCC1)NC1CC1)SC(C(=O)N)C1=CC=CC=C1 XRDSGFIUOVUAFR-HXBUSHRASA-N 0.000 claims 2
TYRGVNLUHJKMQZ-PIVQAISJSA-N 2-[3,5-dicyano-6-[(3S)-3-(diaminomethylideneamino)oxypyrrolidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)ONC(=N)N)SC(C(=O)N)C1=CC=CC=C1 TYRGVNLUHJKMQZ-PIVQAISJSA-N 0.000 claims 2
UXBDLRYUGBZZNB-DJZRFWRSSA-N 2-[3,5-dicyano-6-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)N(C)C)SC(C(=O)N)C1=CC=CC=C1 UXBDLRYUGBZZNB-DJZRFWRSSA-N 0.000 claims 2
UMDFJCAWFVOWTN-XGLRFROISA-N 2-[3,5-dicyano-6-[(3S)-3-[(2,2-dimethylpropylamino)methyl]piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H](CCC1)CNCC(C)(C)C)SC(C(=O)N)C1=CC=CC=C1 UMDFJCAWFVOWTN-XGLRFROISA-N 0.000 claims 2
JVFVJIMPWTUARY-CWQZNGJJSA-N 2-[3,5-dicyano-6-[(3S)-3-hydroxypyrrolidin-1-yl]-4-methoxypyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1OC)C#N)N1C[C@H](CC1)O)SC(C(=O)N)C1=CC=CC=C1 JVFVJIMPWTUARY-CWQZNGJJSA-N 0.000 claims 2
YNRHPBVVQIDNPF-JWTNVVGKSA-N 2-[3,5-dicyano-6-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H]([C@@H](C1)O)O)SC(C(=O)N)C1=CC=CC=C1 YNRHPBVVQIDNPF-JWTNVVGKSA-N 0.000 claims 2
PJLCPZDEFOJRNH-DBIVSCPCSA-N 2-[3,5-dicyano-6-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H](N[C@@H](C1)C)C)SC(C(=O)N)C1=CC=CC=C1 PJLCPZDEFOJRNH-DBIVSCPCSA-N 0.000 claims 2
XMZRJKUIERXLEA-UHFFFAOYSA-N 2-[3,5-dicyano-6-[2-(2,2-dimethylpropylamino)ethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCNCC(C)(C)C)C)SC(C(=O)N)C1=CC=CC=C1 XMZRJKUIERXLEA-UHFFFAOYSA-N 0.000 claims 2
FLQWEYKWBPGAQZ-UHFFFAOYSA-N 2-[3,5-dicyano-6-[2-(cyclopropylmethyl)-2,9-diazaspiro[5.5]undecan-9-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC2(CCCN(C2)CC2CC2)CC1)SC(C(=O)N)C1=CC=CC=C1 FLQWEYKWBPGAQZ-UHFFFAOYSA-N 0.000 claims 2
XXJFYRYKHCNOQK-UHFFFAOYSA-N 2-[3,5-dicyano-6-[2-(diaminomethylideneamino)oxyethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCONC(=N)N)SC(C(=O)N)C1=CC=CC=C1 XXJFYRYKHCNOQK-UHFFFAOYSA-N 0.000 claims 2
BIZYAOCWRROOTD-UHFFFAOYSA-N 2-[3,5-dicyano-6-[2-(diethylamino)ethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN(CC)CC)SC(C(=O)N)C1=CC=CC=C1 BIZYAOCWRROOTD-UHFFFAOYSA-N 0.000 claims 2
AXKAVBGAZHPOHC-UHFFFAOYSA-N 2-[3,5-dicyano-6-[2-(diethylaminomethyl)morpholin-4-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(OCC1)CN(CC)CC)SC(C(=O)N)C1=CC=CC=C1 AXKAVBGAZHPOHC-UHFFFAOYSA-N 0.000 claims 2
QBTLPLHSROYOIB-UHFFFAOYSA-N 2-[3,5-dicyano-6-[2-(dimethylamino)ethoxy]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)OCCN(C)C)SC(C(=O)N)C1=CC=CC=C1 QBTLPLHSROYOIB-UHFFFAOYSA-N 0.000 claims 2
CMFOAXMRKJAQAS-UHFFFAOYSA-N 2-[3,5-dicyano-6-[2-(dimethylamino)ethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN(C)C)SC(C(=O)N)C1=CC=CC=C1 CMFOAXMRKJAQAS-UHFFFAOYSA-N 0.000 claims 2
XDSCOQKNRNKTDB-UHFFFAOYSA-N 2-[3,5-dicyano-6-[2-(dimethylamino)ethylsulfanyl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)SCCN(C)C)SC(C(=O)N)C1=CC=CC=C1 XDSCOQKNRNKTDB-UHFFFAOYSA-N 0.000 claims 2
GJEASOAIHWLCJZ-JGUPTHKFSA-N 2-[3,5-dicyano-6-[2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]ethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN1[C@@H](CC[C@H]1C)C)SC(C(=O)N)C1=CC=CC=C1 GJEASOAIHWLCJZ-JGUPTHKFSA-N 0.000 claims 2
GJEASOAIHWLCJZ-NHJWOMDBSA-N 2-[3,5-dicyano-6-[2-[(2R,5S)-2,5-dimethylpyrrolidin-1-yl]ethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN1[C@H](CC[C@H]1C)C)SC(C(=O)N)C1=CC=CC=C1 GJEASOAIHWLCJZ-NHJWOMDBSA-N 0.000 claims 2
GJEASOAIHWLCJZ-JOHXPNBHSA-N 2-[3,5-dicyano-6-[2-[(2S,5S)-2,5-dimethylpyrrolidin-1-yl]ethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN1[C@H](CC[C@@H]1C)C)SC(C(=O)N)C1=CC=CC=C1 GJEASOAIHWLCJZ-JOHXPNBHSA-N 0.000 claims 2
NITLTHGIWLRPFL-HWYAHNCWSA-N 2-[3,5-dicyano-6-[2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]ethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN1C[C@@H](CC1)N(C)C)SC(C(=O)N)C1=CC=CC=C1 NITLTHGIWLRPFL-HWYAHNCWSA-N 0.000 claims 2
NITLTHGIWLRPFL-HSTJUUNISA-N 2-[3,5-dicyano-6-[2-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]ethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN1C[C@H](CC1)N(C)C)SC(C(=O)N)C1=CC=CC=C1 NITLTHGIWLRPFL-HSTJUUNISA-N 0.000 claims 2
ZGBWULPYTNVDDE-UHFFFAOYSA-N 2-[3,5-dicyano-6-[3-(diaminomethylideneamino)oxyazetidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(C1)ONC(=N)N)SC(C(=O)N)C1=CC=CC=C1 ZGBWULPYTNVDDE-UHFFFAOYSA-N 0.000 claims 2
OGHLVJPRXFDONV-UHFFFAOYSA-N 2-[3,5-dicyano-6-[3-[(dimethylamino)methyl]piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(CCC1)CN(C)C)SC(C(=O)N)C1=CC=CC=C1 OGHLVJPRXFDONV-UHFFFAOYSA-N 0.000 claims 2
CPKKLVQNKMXDBL-UHFFFAOYSA-N 2-[3,5-dicyano-6-[3-[(dimethylamino)methyl]pyrrolidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(CC1)CN(C)C)SC(C(=O)N)C1=CC=CC=C1 CPKKLVQNKMXDBL-UHFFFAOYSA-N 0.000 claims 2
MQDOWKIITDXHFY-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(2,2-difluoroethylamino)-4-methylpiperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)(C)NCC(F)F)SC(C(=O)N)C1=CC=CC=C1 MQDOWKIITDXHFY-UHFFFAOYSA-N 0.000 claims 2
NRXLLIYFPGEQKW-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(2,2-difluoroethylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCC(F)F)SC(C(=O)N)C1=CC=CC=C1 NRXLLIYFPGEQKW-UHFFFAOYSA-N 0.000 claims 2
KYWHKTGBQIOFPC-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(2,2-dimethylpropylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCC(C)(C)C)SC(C(=O)N)C1=CC=C(C=C1)F KYWHKTGBQIOFPC-UHFFFAOYSA-N 0.000 claims 2
NUOFNLUIHZRQHJ-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(2,2-dimethylpropylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCC(C)(C)C)SC(C(=O)N)C1=CC=CC=C1 NUOFNLUIHZRQHJ-UHFFFAOYSA-N 0.000 claims 2
JCXGKQLJABWGKP-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(2,5-dioxoimidazolidin-1-yl)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1C(NCC1=O)=O)SC(C(=O)N)C1=CC=CC=C1 JCXGKQLJABWGKP-UHFFFAOYSA-N 0.000 claims 2
FZYBTOYDEPQYRI-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]-4-methoxypyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1OC)C#N)N1CCN(CCC1)CCO)SC(C(=O)N)C1=CC=CC=C1 FZYBTOYDEPQYRI-UHFFFAOYSA-N 0.000 claims 2
WBNRGSXBRABHNI-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]-4-propoxypyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1OCCC)C#N)N1CCN(CCC1)CCO)SC(C(=O)N)C1=CC=CC=C1 WBNRGSXBRABHNI-UHFFFAOYSA-N 0.000 claims 2
KKHSDHHCWMBFOK-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1CC(CC1)(F)F)SC(C(=O)N)C1=CC=CC=C1 KKHSDHHCWMBFOK-UHFFFAOYSA-N 0.000 claims 2
OHYCOVOLCLJBIQ-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(cyclobutylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NC1CCC1)SC(C(=O)N)C1=CC=CC=C1 OHYCOVOLCLJBIQ-UHFFFAOYSA-N 0.000 claims 2
BZCKIEYSRQOOEW-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(cyclopropylamino)-3-fluoropiperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(C(CC1)NC1CC1)F)SC(C(=O)N)C1=CC=CC=C1 BZCKIEYSRQOOEW-UHFFFAOYSA-N 0.000 claims 2
WLGBTBSZMJKZFA-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(cyclopropylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NC1CC1)SC(C(=O)N)C1=CC=CC=C1 WLGBTBSZMJKZFA-UHFFFAOYSA-N 0.000 claims 2
BUFHWVIJQMGNTB-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(diaminomethylideneamino)oxypiperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)ONC(=N)N)SC(C(=O)N)C1=CC=CC=C1 BUFHWVIJQMGNTB-UHFFFAOYSA-N 0.000 claims 2
DICLIVFTTAAJBE-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(dimethylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-(2,4-difluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)C)SC(C(=O)N)C1=C(C=C(C=C1)F)F DICLIVFTTAAJBE-UHFFFAOYSA-N 0.000 claims 2
COCVXPUQYSCVKV-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(dimethylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-(3,4-difluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)C)SC(C(=O)N)C1=CC(=C(C=C1)F)F COCVXPUQYSCVKV-UHFFFAOYSA-N 0.000 claims 2
MELQQCMEXPGRLW-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(dimethylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)C)SC(C(=O)N)C1=CC=CC=C1 MELQQCMEXPGRLW-UHFFFAOYSA-N 0.000 claims 2
JMHYFCLKDJIHGI-CKPMZPGQSA-N 2-[3,5-dicyano-6-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1[C@@H](CC[C@H]1C)C)SC(C(=O)N)C1=CC=CC=C1 JMHYFCLKDJIHGI-CKPMZPGQSA-N 0.000 claims 2
JMHYFCLKDJIHGI-OOEJVQDLSA-N 2-[3,5-dicyano-6-[4-[(2R,5S)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1[C@@H](CC[C@@H]1C)C)SC(C(=O)N)C1=CC=CC=C1 JMHYFCLKDJIHGI-OOEJVQDLSA-N 0.000 claims 2
JMHYFCLKDJIHGI-NHDFCTKWSA-N 2-[3,5-dicyano-6-[4-[(2S,5S)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1[C@H](CC[C@@H]1C)C)SC(C(=O)N)C1=CC=CC=C1 JMHYFCLKDJIHGI-NHDFCTKWSA-N 0.000 claims 2
SGDORTBLSHVRCN-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-[3-(dimethylamino)propyl]piperazin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CCCN(C)C)SC(C(=O)N)C1=CC=CC=C1 SGDORTBLSHVRCN-UHFFFAOYSA-N 0.000 claims 2
WAUGZLFVUIBDBC-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-[cyclobutyl(methyl)amino]piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)C1CCC1)SC(C(=O)N)C1=CC=C(C=C1)F WAUGZLFVUIBDBC-UHFFFAOYSA-N 0.000 claims 2
WYIMAUGPLBALGL-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-[cyclobutyl(methyl)amino]piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)C1CCC1)SC(C(=O)N)C1=CC=CC=C1 WYIMAUGPLBALGL-UHFFFAOYSA-N 0.000 claims 2
IRHOOYHPPHGTRC-UHFFFAOYSA-N 2-[3,5-dicyano-6-[[2-(1,3-dihydroxypropan-2-ylamino)-2-oxoethyl]-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NC(CO)CO)C)C#N)CC)C#N)=O IRHOOYHPPHGTRC-UHFFFAOYSA-N 0.000 claims 2
JOXMAWTUMNYVAU-AQFHOAJTSA-N 2-[3,5-dicyano-6-[[2-[(3R,4R)-3,4-dihydroxypyrrolidin-1-yl]-2-oxoethyl]-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@H]([C@@H](C1)O)O)SC(C(=O)N)C1=CC=CC=C1 JOXMAWTUMNYVAU-AQFHOAJTSA-N 0.000 claims 2
JOXMAWTUMNYVAU-PMSBKCLSSA-N 2-[3,5-dicyano-6-[[2-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-2-oxoethyl]-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@H]([C@H](C1)O)O)SC(C(=O)N)C1=CC=CC=C1 JOXMAWTUMNYVAU-PMSBKCLSSA-N 0.000 claims 2
JOXMAWTUMNYVAU-CHEUHSMRSA-N 2-[3,5-dicyano-6-[[2-[(3S,4S)-3,4-dihydroxypyrrolidin-1-yl]-2-oxoethyl]-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@@H]([C@H](C1)O)O)SC(C(=O)N)C1=CC=CC=C1 JOXMAWTUMNYVAU-CHEUHSMRSA-N 0.000 claims 2
TUGBHEYYCADQIE-AQKKSAQBSA-N 2-[3,5-dicyano-6-[[2-[(3S,5R)-3,5-dihydroxypiperidin-1-yl]-2-oxoethyl]-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@@H](C[C@@H](C1)O)O)SC(C(=O)N)C1=CC=CC=C1 TUGBHEYYCADQIE-AQKKSAQBSA-N 0.000 claims 2
RHNQQNKFFAMZHT-IWPPFLRJSA-N 2-[3,5-dicyano-6-[[2-[[(2R)-2,3-dihydroxypropyl]amino]-2-oxoethyl]-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NC[C@H](CO)O)C)C#N)CC)C#N)=O RHNQQNKFFAMZHT-IWPPFLRJSA-N 0.000 claims 2
IMKNMPXUIJTVKF-UHFFFAOYSA-N 2-[4-(2-amino-2-oxoethyl)phenyl]-2-[3,5-dicyano-4-ethyl-6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanylacetamide Chemical compound NC(CC1=CC=C(C=C1)C(C(=O)N)SC1=NC(=C(C(=C1C#N)CC)C#N)N1CCN(CCC1)C)=O IMKNMPXUIJTVKF-UHFFFAOYSA-N 0.000 claims 2
MBQJFQOCMNTMNQ-UHFFFAOYSA-N 2-[4-(2-amino-2-oxoethyl)phenyl]-2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanylacetamide Chemical compound NC(CC1=CC=C(C=C1)C(C(=O)N)SC1=NC(=C(C(=C1C#N)CC)C#N)N(C)C)=O MBQJFQOCMNTMNQ-UHFFFAOYSA-N 0.000 claims 2
LZZBRZDORPAYHM-UHFFFAOYSA-N 2-[6-(1,3,4,5,7,8,9,9a-octahydropyrrolo[1,2-a][1,4]diazepin-2-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC2N(CCC1)CCC2)SC(C(=O)N)C1=CC=CC=C1 LZZBRZDORPAYHM-UHFFFAOYSA-N 0.000 claims 2
PPXIQBJVGVIWDI-UHFFFAOYSA-N 2-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)SC(C(=O)N)C1=CC=CC=C1)SC(C(=O)N)C1=CC=CC=C1 PPXIQBJVGVIWDI-UHFFFAOYSA-N 0.000 claims 2
IKEVWYBPAUJEDN-UHFFFAOYSA-N 2-[6-(2-amino-2-oxoethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(CSC1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)=O IKEVWYBPAUJEDN-UHFFFAOYSA-N 0.000 claims 2
AUSILSIUFIKOSS-UHFFFAOYSA-N 2-[6-(3,4,4a,5,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazin-6-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC2OCCNC2C1)SC(C(=O)N)C1=CC=CC=C1 AUSILSIUFIKOSS-UHFFFAOYSA-N 0.000 claims 2
ZGFSVDFCYOMEJY-UHFFFAOYSA-N 2-[6-(3-aminopiperidin-1-yl)-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CN(CCC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N ZGFSVDFCYOMEJY-UHFFFAOYSA-N 0.000 claims 2
WOFWYIKKGDFRKO-UHFFFAOYSA-N 2-[6-(4-acetylpiperazin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(C)(=O)N1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N WOFWYIKKGDFRKO-UHFFFAOYSA-N 0.000 claims 2
LWCTZINLTSJCET-UHFFFAOYSA-N 2-[6-(4-amino-3,3-difluoropiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1C(CN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)(F)F LWCTZINLTSJCET-UHFFFAOYSA-N 0.000 claims 2
BEWQRCQQIKNSEB-UHFFFAOYSA-N 2-[6-(4-amino-4-methylpiperidin-1-yl)-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1(CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N)C BEWQRCQQIKNSEB-UHFFFAOYSA-N 0.000 claims 2
ALNFMEKLSGMBDG-UHFFFAOYSA-N 2-[6-(4-aminopiperazin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N ALNFMEKLSGMBDG-UHFFFAOYSA-N 0.000 claims 2
UTKLFRLMLLGCFI-UHFFFAOYSA-N 2-[6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N UTKLFRLMLLGCFI-UHFFFAOYSA-N 0.000 claims 2
MUZQFFCMSJIQRT-UHFFFAOYSA-N 2-[6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-(3-fluoropyridin-2-yl)acetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=NC=CC=C1F)C#N)CC)C#N MUZQFFCMSJIQRT-UHFFFAOYSA-N 0.000 claims 2
CZNRJQMBRCCVPE-UHFFFAOYSA-N 2-[6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=C(C=C1)F)C#N)CC)C#N CZNRJQMBRCCVPE-UHFFFAOYSA-N 0.000 claims 2
HCPBFQRBYJPHKZ-UHFFFAOYSA-N 2-[6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-[4-(trifluoromethyl)phenyl]acetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=C(C=C1)C(F)(F)F)C#N)CC)C#N HCPBFQRBYJPHKZ-UHFFFAOYSA-N 0.000 claims 2
KNKHRZYILDZLRE-UHFFFAOYSA-N 2-[6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N KNKHRZYILDZLRE-UHFFFAOYSA-N 0.000 claims 2
OYAWXAXYBNYPBS-UHFFFAOYSA-N 2-[6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-methoxypyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)OC)C#N OYAWXAXYBNYPBS-UHFFFAOYSA-N 0.000 claims 2
UOBFRXJLZIFHJN-UHFFFAOYSA-N 2-[6-(4-aminopiperidin-1-yl)-3-cyano-4-ethyl-5-methylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C UOBFRXJLZIFHJN-UHFFFAOYSA-N 0.000 claims 2
QPYOXRCZBIGMHI-UHFFFAOYSA-N 2-[6-(4-benzoylpiperazin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(C1=CC=CC=C1)(=O)N1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N QPYOXRCZBIGMHI-UHFFFAOYSA-N 0.000 claims 2
SRZPYPCNFUTKLJ-UHFFFAOYSA-N 2-[6-(azetidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1(CCC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N SRZPYPCNFUTKLJ-UHFFFAOYSA-N 0.000 claims 2
WEGOHWICAIDWSC-UHFFFAOYSA-N 2-[6-[(2-amino-2-oxoethyl)-methylamino]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(CN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N)C)=O WEGOHWICAIDWSC-UHFFFAOYSA-N 0.000 claims 2
PMWNNSZNZVXNKL-NYRJJRHWSA-N 2-[6-[(2R)-2-(aminomethyl)morpholin-4-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC[C@H]1OCCN(C1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N PMWNNSZNZVXNKL-NYRJJRHWSA-N 0.000 claims 2
LNKYKKANMBILNL-UJONTBEJSA-N 2-[6-[(2R)-2-[[(2-aminoacetyl)amino]methyl]morpholin-4-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC(=O)NC[C@@H]1CN(CCO1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1 LNKYKKANMBILNL-UJONTBEJSA-N 0.000 claims 2
PMWNNSZNZVXNKL-FUKCDUGKSA-N 2-[6-[(2S)-2-(aminomethyl)morpholin-4-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC[C@@H]1OCCN(C1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N PMWNNSZNZVXNKL-FUKCDUGKSA-N 0.000 claims 2
LNKYKKANMBILNL-BJQOMGFOSA-N 2-[6-[(2S)-2-[[(2-aminoacetyl)amino]methyl]morpholin-4-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC(=O)NC[C@H]1CN(CCO1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1 LNKYKKANMBILNL-BJQOMGFOSA-N 0.000 claims 2
RNQDUYUPMICSPU-UHFFFAOYSA-N 2-[6-[(3-aminocyclobutyl)-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CC(C1)N(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C RNQDUYUPMICSPU-UHFFFAOYSA-N 0.000 claims 2
SLFVOEJIFPFHPQ-LMNIDFBRSA-N 2-[6-[(3R)-3-(aminomethyl)-3-fluoropyrrolidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC[C@]1(CN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F SLFVOEJIFPFHPQ-LMNIDFBRSA-N 0.000 claims 2
FFCIAYQYQHQCAI-NYRJJRHWSA-N 2-[6-[(3R)-3-aminopiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@H]1CN(CCC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N FFCIAYQYQHQCAI-NYRJJRHWSA-N 0.000 claims 2
KBEGRXPEEBEXGI-IKJXHCRLSA-N 2-[6-[(3R)-3-aminopyrrolidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@H]1CN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N KBEGRXPEEBEXGI-IKJXHCRLSA-N 0.000 claims 2
XQNVHJPYTYGCQE-OOJLDXBWSA-N 2-[6-[(3S)-3-(aminomethyl)piperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC[C@H]1CN(CCC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N XQNVHJPYTYGCQE-OOJLDXBWSA-N 0.000 claims 2
GYGKBXDKKKPZHQ-CISYCMJJSA-N 2-[6-[(3S)-3-[[(2-aminoacetyl)amino]methyl]piperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC(=O)NC[C@H]1CN(CCC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1 GYGKBXDKKKPZHQ-CISYCMJJSA-N 0.000 claims 2
FFCIAYQYQHQCAI-FUKCDUGKSA-N 2-[6-[(3S)-3-aminopiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@@H]1CN(CCC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N FFCIAYQYQHQCAI-FUKCDUGKSA-N 0.000 claims 2
XSBOMFPXGIVJLB-FUKCDUGKSA-N 2-[6-[(3S)-3-aminopyrrolidin-1-yl]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@@H]1CN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N XSBOMFPXGIVJLB-FUKCDUGKSA-N 0.000 claims 2
KBEGRXPEEBEXGI-PIVQAISJSA-N 2-[6-[(3S)-3-aminopyrrolidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@@H]1CN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N KBEGRXPEEBEXGI-PIVQAISJSA-N 0.000 claims 2
YWBVSTLJPZTNFH-UHFFFAOYSA-N 2-[6-[2-(2-aminoethoxy)ethyl-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCOCCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C YWBVSTLJPZTNFH-UHFFFAOYSA-N 0.000 claims 2
PMWNNSZNZVXNKL-UHFFFAOYSA-N 2-[6-[2-(aminomethyl)morpholin-4-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC1OCCN(C1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N PMWNNSZNZVXNKL-UHFFFAOYSA-N 0.000 claims 2
JVYSQUPZSLVXHG-UHFFFAOYSA-N 2-[6-[2-(azepan-1-yl)ethyl-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1(CCCCCC1)CCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C JVYSQUPZSLVXHG-UHFFFAOYSA-N 0.000 claims 2
XCJYJCQYRHMCIO-OQHSHRKDSA-N 2-[6-[2-[(3R)-3-aminopyrrolidin-1-yl]ethyl-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@H]1CN(CC1)CCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C XCJYJCQYRHMCIO-OQHSHRKDSA-N 0.000 claims 2
XCJYJCQYRHMCIO-PBVYKCSPSA-N 2-[6-[2-[(3S)-3-aminopyrrolidin-1-yl]ethyl-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@@H]1CN(CC1)CCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C XCJYJCQYRHMCIO-PBVYKCSPSA-N 0.000 claims 2
QDSUGZANEFECHV-UHFFFAOYSA-N 2-[6-[2-[4-(aminomethyl)-4-hydroxypiperidin-1-yl]ethyl-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC1(CCN(CC1)CCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C)O QDSUGZANEFECHV-UHFFFAOYSA-N 0.000 claims 2
KQXPWVJENBGGLC-UHFFFAOYSA-N 2-[6-[2-aminoethyl(methyl)amino]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N)C KQXPWVJENBGGLC-UHFFFAOYSA-N 0.000 claims 2
FGEUXSPNUVMYFN-UHFFFAOYSA-N 2-[6-[2-aminoethyl(methyl)amino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C FGEUXSPNUVMYFN-UHFFFAOYSA-N 0.000 claims 2
GEDMGGLPWSSKKL-UHFFFAOYSA-N 2-[6-[3-(2-amino-2-oxoethyl)azetidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(CC1CN(C1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)=O GEDMGGLPWSSKKL-UHFFFAOYSA-N 0.000 claims 2
BNSFJHRMFNFDAG-UHFFFAOYSA-N 2-[6-[3-(aminomethyl)-3-fluoroazetidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC1(CN(C1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F BNSFJHRMFNFDAG-UHFFFAOYSA-N 0.000 claims 2
OQGJRMRSVCAYGC-UHFFFAOYSA-N 2-[6-[3-(aminomethyl)azetidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC1CN(C1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N OQGJRMRSVCAYGC-UHFFFAOYSA-N 0.000 claims 2
NZDNIYAPZBEWSL-UHFFFAOYSA-N 2-[6-[3-(aminomethyl)pyrrolidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC1CN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N NZDNIYAPZBEWSL-UHFFFAOYSA-N 0.000 claims 2
ZZEYJFMVGDINRK-UHFFFAOYSA-N 2-[6-[3-aminopropyl(methyl)amino]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N)C ZZEYJFMVGDINRK-UHFFFAOYSA-N 0.000 claims 2
VWIPKZUTTPRYHJ-UHFFFAOYSA-N 2-[6-[3-aminopropyl(methyl)amino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C VWIPKZUTTPRYHJ-UHFFFAOYSA-N 0.000 claims 2
RJOBZQUOAKRYGL-UHFFFAOYSA-N 2-[6-[4-(2-aminoethoxy)piperidin-1-yl]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCOC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N RJOBZQUOAKRYGL-UHFFFAOYSA-N 0.000 claims 2
BLZTZJSUGNBLSO-UHFFFAOYSA-N 2-[6-[4-(2-aminoethoxy)piperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCOC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N BLZTZJSUGNBLSO-UHFFFAOYSA-N 0.000 claims 2
MAFFWBYHTVLIIC-UHFFFAOYSA-N 2-[6-[4-(2-aminoethyl)piperazin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N MAFFWBYHTVLIIC-UHFFFAOYSA-N 0.000 claims 2
ITNCPVQXCAIRIB-UHFFFAOYSA-N 2-[6-[4-(2-aminoethylamino)piperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCNC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N ITNCPVQXCAIRIB-UHFFFAOYSA-N 0.000 claims 2
WXFQMTXWVFGFAT-UHFFFAOYSA-N 2-[6-[4-(3-amino-2-oxopyrrolidin-1-yl)piperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1C(N(CC1)C1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)=O WXFQMTXWVFGFAT-UHFFFAOYSA-N 0.000 claims 2
UFWLOSHEGGYLCG-UHFFFAOYSA-N 2-[6-[4-(3-aminooxetane-3-carbonyl)piperazin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1(COC1)C(=O)N1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N UFWLOSHEGGYLCG-UHFFFAOYSA-N 0.000 claims 2
VSKHLYUJBSIEJD-UHFFFAOYSA-N 2-[6-[4-(3-aminopropyl)piperazin-1-yl]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCCN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N VSKHLYUJBSIEJD-UHFFFAOYSA-N 0.000 claims 2
VPSZPHFSSKMVRD-UHFFFAOYSA-N 2-[6-[4-(3-aminopropyl)piperazin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCCN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N VPSZPHFSSKMVRD-UHFFFAOYSA-N 0.000 claims 2
QNPCTZHGKDIXRX-UHFFFAOYSA-N 2-[6-[4-(4-aminooxane-4-carbonyl)piperazin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1(CCOCC1)C(=O)N1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N QNPCTZHGKDIXRX-UHFFFAOYSA-N 0.000 claims 2
VZGOPXHEQIDXJK-UHFFFAOYSA-N 2-[6-[4-(4-bromobenzoyl)piperazin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound BrC1=CC=C(C(=O)N2CCN(CC2)C2=C(C(=C(C(=N2)SC(C(=O)N)C2=CC=CC=C2)C#N)CC)C#N)C=C1 VZGOPXHEQIDXJK-UHFFFAOYSA-N 0.000 claims 2
OUYJFIBXLUPLFP-UHFFFAOYSA-N 2-[6-[4-(aminomethyl)-4-fluoropiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide hydrochloride Chemical compound Cl.CCc1c(C#N)c(SC(C(N)=O)c2ccccc2)nc(N2CCC(F)(CN)CC2)c1C#N OUYJFIBXLUPLFP-UHFFFAOYSA-N 0.000 claims 2
PHKYZYTYHPGLTD-UHFFFAOYSA-N 2-[6-[4-(aminomethyl)-4-hydroxypiperidin-1-yl]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC1(CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N)O PHKYZYTYHPGLTD-UHFFFAOYSA-N 0.000 claims 2
ORQSOUJPOUNSOO-UHFFFAOYSA-N 2-[6-[4-(aminomethyl)-4-hydroxypiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC1(CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)O ORQSOUJPOUNSOO-UHFFFAOYSA-N 0.000 claims 2
GRSYUHUEJLXKJY-UHFFFAOYSA-N 2-[6-[4-(benzenesulfonyl)piperazin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)S(=O)(=O)C1=CC=CC=C1)SC(C(=O)N)C1=CC=CC=C1 GRSYUHUEJLXKJY-UHFFFAOYSA-N 0.000 claims 2
KMSVUGZZCMCBRE-UHFFFAOYSA-N 2-[6-[4-(benzylamino)piperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(C1=CC=CC=C1)NC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N KMSVUGZZCMCBRE-UHFFFAOYSA-N 0.000 claims 2
TXNOJGRGASUJRM-UHFFFAOYSA-N 2-[6-[4-[(2-amino-2-oxoethyl)amino]piperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(CNC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)=O TXNOJGRGASUJRM-UHFFFAOYSA-N 0.000 claims 2
VHBPEOQXYPCLBX-UHFFFAOYSA-N 2-[6-[4-amino-4-(hydroxymethyl)piperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1(CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)CO VHBPEOQXYPCLBX-UHFFFAOYSA-N 0.000 claims 2
NXJFBTGSTBPGSE-UHFFFAOYSA-N 2-[6-[8-azabicyclo[3.2.1]octan-3-yl(methyl)amino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C12CC(CC(CC1)N2)N(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C NXJFBTGSTBPGSE-UHFFFAOYSA-N 0.000 claims 2
YDZPPICNOQHQEC-UHFFFAOYSA-N 2-[6-[[2-(2-aminoethylamino)-2-oxoethyl]-methylamino]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide hydrochloride Chemical compound Cl.CN(CC(=O)NCCN)c1nc(SC(C(N)=O)c2ccccc2)c(C#N)c(C2CC2)c1C#N YDZPPICNOQHQEC-UHFFFAOYSA-N 0.000 claims 2
PDQXUGIJXRCATP-UHFFFAOYSA-N 2-[6-[[2-(2-aminoethylamino)-2-oxoethyl]-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NCCN)C)C#N)CC)C#N)=O PDQXUGIJXRCATP-UHFFFAOYSA-N 0.000 claims 2
NXUFAFHTUATDHM-UHFFFAOYSA-N 2-[6-[[2-(azetidin-1-yl)-2-oxoethyl]-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1(CCC1)C(CN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C)=O NXUFAFHTUATDHM-UHFFFAOYSA-N 0.000 claims 2
LDXIFMPGKWMLRA-UHFFFAOYSA-N 2-[6-[[2-[bis(2-hydroxyethyl)amino]-2-oxoethyl]-methylamino]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)N(CCO)CCO)C)C#N)C1CC1)C#N)=O LDXIFMPGKWMLRA-UHFFFAOYSA-N 0.000 claims 2
PWKQIYKPPHHUCG-UHFFFAOYSA-N 2-[6-[[2-[bis(2-hydroxyethyl)amino]-2-oxoethyl]-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)N(CCO)CCO)C)C#N)CC)C#N)=O PWKQIYKPPHHUCG-UHFFFAOYSA-N 0.000 claims 2
UDLKSJKVQWSPIW-UHFFFAOYSA-N 2-[[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-cyclopropylpyridin-2-yl]piperidin-3-yl]amino]acetic acid Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1CC(CCC1)NCC(=O)O)C#N)C1CC1)C#N)=O UDLKSJKVQWSPIW-UHFFFAOYSA-N 0.000 claims 2
FMPXFUQXHLFWGA-UHFFFAOYSA-N 2-[[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidin-4-yl]amino]acetic acid Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1CCC(CC1)NCC(=O)O)C#N)CC)C#N)=O FMPXFUQXHLFWGA-UHFFFAOYSA-N 0.000 claims 2
MQMOQJRQUDYHIT-UHFFFAOYSA-N 2-[[4-cyano-3-(1,4-diazepan-1-yl)-6,7-dihydro-5H-cyclopenta[c]pyridin-1-yl]sulfanyl]-2-phenylacetamide Chemical compound C(#N)C=1C2=C(C(=NC=1N1CCNCCC1)SC(C(=O)N)C1=CC=CC=C1)CCC2 MQMOQJRQUDYHIT-UHFFFAOYSA-N 0.000 claims 2
IKVXIXHNROKJNB-UHFFFAOYSA-N 2-[[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-cyclopropylpyridin-2-yl]-methylamino]ethyl carbamate Chemical compound C(N)(OCCN(C)C1=NC(=C(C(=C1C#N)C1CC1)C#N)SC(C(=O)N)C1=CC=CC=C1)=O IKVXIXHNROKJNB-UHFFFAOYSA-N 0.000 claims 2
MCEDGEJMPSOBJC-UHFFFAOYSA-N 2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-cyclopropylpyridin-2-yl]piperidin-4-yl]-2-methylpropanamide Chemical compound NC(C(=O)NC1CCN(CC1)C1=NC(=C(C(=C1C#N)C1CC1)C#N)SC(C(=O)N)C1=CC=CC=C1)(C)C MCEDGEJMPSOBJC-UHFFFAOYSA-N 0.000 claims 2
BRFPBSADPQNVNY-UHFFFAOYSA-N 2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidin-4-yl]-2-methylpropanamide Chemical compound NC(C(=O)NC1CCN(CC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)(C)C BRFPBSADPQNVNY-UHFFFAOYSA-N 0.000 claims 2
MTYKWTDQRMWOKT-UHFFFAOYSA-N 2-amino-N-[2-[[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]-methylamino]ethyl]-2-methylpropanamide Chemical compound NC(C(=O)NCCN(C)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)(C)C MTYKWTDQRMWOKT-UHFFFAOYSA-N 0.000 claims 2
NDIYHVIIZPPWEE-OQHSHRKDSA-N 2-amino-N-[[(2R)-4-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]morpholin-2-yl]methyl]-2-methylpropanamide Chemical compound NC(C(=O)NC[C@@H]1CN(CCO1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)(C)C NDIYHVIIZPPWEE-OQHSHRKDSA-N 0.000 claims 2
NDIYHVIIZPPWEE-PBVYKCSPSA-N 2-amino-N-[[(2S)-4-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]morpholin-2-yl]methyl]-2-methylpropanamide Chemical compound NC(C(=O)NC[C@H]1CN(CCO1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)(C)C NDIYHVIIZPPWEE-PBVYKCSPSA-N 0.000 claims 2
PJISFTNPCBHBNK-LBOXEOMUSA-N 2-amino-N-[[(3S)-1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidin-3-yl]methyl]-2-methylpropanamide Chemical compound NC(C(=O)NC[C@H]1CN(CCC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)(C)C PJISFTNPCBHBNK-LBOXEOMUSA-N 0.000 claims 2
LSBDFXRDZJMBSC-UHFFFAOYSA-N 2-phenylacetamide Chemical compound NC(=O)CC1=CC=CC=C1 LSBDFXRDZJMBSC-UHFFFAOYSA-N 0.000 claims 2
KINCARDDMQLNIL-UHFFFAOYSA-N 3-[[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]-methylamino]-2-hydroxy-2-methylpropanamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(C(=O)N)(C)O)C)C#N)CC)C#N)=O KINCARDDMQLNIL-UHFFFAOYSA-N 0.000 claims 2
WEBHAPVDDKHLJW-UHFFFAOYSA-N 3-[[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]-methylamino]propanamide Chemical compound NC(C(SC1=C(C(=C(C(=N1)N(CCC(=O)N)C)C#N)CC)C#N)C1=CC=CC=C1)=O WEBHAPVDDKHLJW-UHFFFAOYSA-N 0.000 claims 2
VXEACFIHCXTPDL-UHFFFAOYSA-N 4-[2-amino-1-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-oxoethyl]benzamide Chemical compound NC(C(SC1=NC(=C(C(=C1C#N)CC)C#N)N(C)C)C1=CC=C(C(=O)N)C=C1)=O VXEACFIHCXTPDL-UHFFFAOYSA-N 0.000 claims 2
NIAKRPGWCWLBBG-UHFFFAOYSA-N 4-amino-1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidine-4-carboxamide Chemical compound NC1(CCN(CC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)C(=O)N NIAKRPGWCWLBBG-UHFFFAOYSA-N 0.000 claims 2
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 2
CENZDQUQOPAJAS-UHFFFAOYSA-N C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CC1=NNC(N1)=O)C)SC(C(=O)N)C1=CC=CC=C1 Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CC1=NNC(N1)=O)C)SC(C(=O)N)C1=CC=CC=C1 CENZDQUQOPAJAS-UHFFFAOYSA-N 0.000 claims 2
SMXWQGIDIGGEGD-UHFFFAOYSA-N C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(OCC1)CN(C)C)SC(C(=O)N)C1=CC=CC=C1 Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(OCC1)CN(C)C)SC(C(=O)N)C1=CC=CC=C1 SMXWQGIDIGGEGD-UHFFFAOYSA-N 0.000 claims 2
OECXPPLXPCZWBO-UHFFFAOYSA-N C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(CC(C)(C)C)C)SC(C(=O)N)C1=CC=CC=C1 Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(CC(C)(C)C)C)SC(C(=O)N)C1=CC=CC=C1 OECXPPLXPCZWBO-UHFFFAOYSA-N 0.000 claims 2
XRWCHQASSTZBPG-QFADGXAASA-N C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CCC1)CNCC(C)(C)C)SC(C(=O)N)C1=CC=C(C=C1)F Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CCC1)CNCC(C)(C)C)SC(C(=O)N)C1=CC=C(C=C1)F XRWCHQASSTZBPG-QFADGXAASA-N 0.000 claims 2
108010009540 DNA (Cytosine-5-)-Methyltransferase 1 Proteins 0.000 claims 2
102100036279 DNA (cytosine-5)-methyltransferase 1 Human genes 0.000 claims 2
206010016654 Fibrosis Diseases 0.000 claims 2
206010051066 Gastrointestinal stromal tumour Diseases 0.000 claims 2
206010020631 Hypergammaglobulinaemia benign monoclonal Diseases 0.000 claims 2
208000034578 Multiple myelomas Diseases 0.000 claims 2
WRXBNJOISAZOIR-UHFFFAOYSA-N N'-[2-[[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]-methylamino]ethyl]oxamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CCNC(C(=O)N)=O)C)C#N)CC)C#N)=O WRXBNJOISAZOIR-UHFFFAOYSA-N 0.000 claims 2
229910019142 PO4 Inorganic materials 0.000 claims 2
206010035226 Plasma cell myeloma Diseases 0.000 claims 2
208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 2
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 2
KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims 2
239000002246 antineoplastic agent Substances 0.000 claims 2
METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 claims 2
125000004567 azetidin-3-yl group Chemical group N1CC(C1)* 0.000 claims 2
210000000481 breast Anatomy 0.000 claims 2
DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 claims 2
210000004027 cell Anatomy 0.000 claims 2
230000007882 cirrhosis Effects 0.000 claims 2
208000019425 cirrhosis of liver Diseases 0.000 claims 2
208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 claims 2
230000000694 effects Effects 0.000 claims 2
RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical group C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 claims 2
125000001153 fluoro group Chemical group F* 0.000 claims 2
201000011243 gastrointestinal stromal tumor Diseases 0.000 claims 2
125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
230000002401 inhibitory effect Effects 0.000 claims 2
229910052740 iodine Inorganic materials 0.000 claims 2
239000011630 iodine Substances 0.000 claims 2
210000002429 large intestine Anatomy 0.000 claims 2
210000004072 lung Anatomy 0.000 claims 2
238000000034 method Methods 0.000 claims 2
229940017219 methyl propionate Drugs 0.000 claims 2
239000000203 mixture Substances 0.000 claims 2
201000005328 monoclonal gammopathy of uncertain significance Diseases 0.000 claims 2
DGOYLVBDCVINQZ-UHFFFAOYSA-N oxane-4-carboxamide Chemical compound NC(=O)C1CCOCC1 DGOYLVBDCVINQZ-UHFFFAOYSA-N 0.000 claims 2
125000002971 oxazolyl group Chemical group 0.000 claims 2
239000010452 phosphate Substances 0.000 claims 2
125000006308 propyl amino group Chemical group 0.000 claims 2
ZUCWGOUXHFRKCF-UHFFFAOYSA-N tert-butyl N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidin-4-yl]carbamate Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1CCC(CC1)NC(OC(C)(C)C)=O)C#N)CC)C#N)=O ZUCWGOUXHFRKCF-UHFFFAOYSA-N 0.000 claims 2
NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
FGQIKVMUUPNDOL-CQSZACIVSA-N (2r)-2-(6-amino-3,5-dicyano-4-ethylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound CCC1=C(C#N)C(N)=NC(S[C@@H](C(N)=O)C=2C=CC=CC=2)=C1C#N FGQIKVMUUPNDOL-CQSZACIVSA-N 0.000 claims 1
VEEGZPWAAPPXRB-BJMVGYQFSA-N (3e)-3-(1h-imidazol-5-ylmethylidene)-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2\C1=C/C1=CN=CN1 VEEGZPWAAPPXRB-BJMVGYQFSA-N 0.000 claims 1
125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 1
BYIMTTMNMSKOFX-UHFFFAOYSA-N 2-(6-amino-3,5-dicyano-4-cyclopropylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound NC1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N BYIMTTMNMSKOFX-UHFFFAOYSA-N 0.000 claims 1
FGQIKVMUUPNDOL-UHFFFAOYSA-N 2-(6-amino-3,5-dicyano-4-ethylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound CCC1=C(C#N)C(N)=NC(SC(C(N)=O)C=2C=CC=CC=2)=C1C#N FGQIKVMUUPNDOL-UHFFFAOYSA-N 0.000 claims 1
AYFHTZLGPLSXOL-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(methylamino)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)NC)SC(C(=O)N)C1=CC=CC=C1 AYFHTZLGPLSXOL-UHFFFAOYSA-N 0.000 claims 1
125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
NRPURYORSRHBCU-UHFFFAOYSA-N 5-oxa-2-azaspiro[3.4]octane Chemical compound C1NCC11OCCC1 NRPURYORSRHBCU-UHFFFAOYSA-N 0.000 claims 1
DGGKXQQCVPAUEA-UHFFFAOYSA-N 8-azabicyclo[3.2.1]octane Chemical compound C1CCC2CCC1N2 DGGKXQQCVPAUEA-UHFFFAOYSA-N 0.000 claims 1
208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims 1
208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims 1
208000031261 Acute myeloid leukaemia Diseases 0.000 claims 1
208000036762 Acute promyelocytic leukaemia Diseases 0.000 claims 1
208000024827 Alzheimer disease Diseases 0.000 claims 1
208000032467 Aplastic anaemia Diseases 0.000 claims 1
201000001320 Atherosclerosis Diseases 0.000 claims 1
208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims 1
208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims 1
206010005003 Bladder cancer Diseases 0.000 claims 1
206010006187 Breast cancer Diseases 0.000 claims 1
208000026310 Breast neoplasm Diseases 0.000 claims 1
208000011691 Burkitt lymphomas Diseases 0.000 claims 1
206010008342 Cervix carcinoma Diseases 0.000 claims 1
208000010833 Chronic myeloid leukaemia Diseases 0.000 claims 1
206010009944 Colon cancer Diseases 0.000 claims 1
229940123780 DNA topoisomerase I inhibitor Drugs 0.000 claims 1
229940124087 DNA topoisomerase II inhibitor Drugs 0.000 claims 1
208000007342 Diabetic Nephropathies Diseases 0.000 claims 1
102100029722 Ectonucleoside triphosphate diphosphohydrolase 1 Human genes 0.000 claims 1
206010014733 Endometrial cancer Diseases 0.000 claims 1
206010014759 Endometrial neoplasm Diseases 0.000 claims 1
206010014967 Ependymoma Diseases 0.000 claims 1
208000031637 Erythroblastic Acute Leukemia Diseases 0.000 claims 1
208000036566 Erythroleukaemia Diseases 0.000 claims 1
208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
208000006168 Ewing Sarcoma Diseases 0.000 claims 1
208000017604 Hodgkin disease Diseases 0.000 claims 1
208000021519 Hodgkin lymphoma Diseases 0.000 claims 1
208000010747 Hodgkins lymphoma Diseases 0.000 claims 1
101001012447 Homo sapiens Ectonucleoside triphosphate diphosphohydrolase 1 Proteins 0.000 claims 1
101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 claims 1
201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 1
208000005726 Inflammatory Breast Neoplasms Diseases 0.000 claims 1
206010021980 Inflammatory carcinoma of the breast Diseases 0.000 claims 1
208000037396 Intraductal Noninfiltrating Carcinoma Diseases 0.000 claims 1
208000008839 Kidney Neoplasms Diseases 0.000 claims 1
208000000265 Lobular Carcinoma Diseases 0.000 claims 1
206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims 1
206010025323 Lymphomas Diseases 0.000 claims 1
208000000172 Medulloblastoma Diseases 0.000 claims 1
208000035490 Megakaryoblastic Acute Leukemia Diseases 0.000 claims 1
206010027145 Melanocytic naevus Diseases 0.000 claims 1
206010027406 Mesothelioma Diseases 0.000 claims 1
206010027480 Metastatic malignant melanoma Diseases 0.000 claims 1
229940122255 Microtubule inhibitor Drugs 0.000 claims 1
208000003445 Mouth Neoplasms Diseases 0.000 claims 1
201000003793 Myelodysplastic syndrome Diseases 0.000 claims 1
208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims 1
208000033776 Myeloid Acute Leukemia Diseases 0.000 claims 1
208000001894 Nasopharyngeal Neoplasms Diseases 0.000 claims 1
206010061306 Nasopharyngeal cancer Diseases 0.000 claims 1
206010029260 Neuroblastoma Diseases 0.000 claims 1
206010052399 Neuroendocrine tumour Diseases 0.000 claims 1
208000007256 Nevus Diseases 0.000 claims 1
208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims 1
206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
229940124060 PD-1 antagonist Drugs 0.000 claims 1
206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
208000007452 Plasmacytoma Diseases 0.000 claims 1
229940079156 Proteasome inhibitor Drugs 0.000 claims 1
201000004681 Psoriasis Diseases 0.000 claims 1
206010038389 Renal cancer Diseases 0.000 claims 1
208000004337 Salivary Gland Neoplasms Diseases 0.000 claims 1
206010061934 Salivary gland cancer Diseases 0.000 claims 1
206010039710 Scleroderma Diseases 0.000 claims 1
208000000453 Skin Neoplasms Diseases 0.000 claims 1
206010041067 Small cell lung cancer Diseases 0.000 claims 1
208000005718 Stomach Neoplasms Diseases 0.000 claims 1
206010042971 T-cell lymphoma Diseases 0.000 claims 1
208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 claims 1
210000001744 T-lymphocyte Anatomy 0.000 claims 1
208000024313 Testicular Neoplasms Diseases 0.000 claims 1
206010057644 Testis cancer Diseases 0.000 claims 1
102100039360 Toll-like receptor 4 Human genes 0.000 claims 1
239000000365 Topoisomerase I Inhibitor Substances 0.000 claims 1
239000000317 Topoisomerase II Inhibitor Substances 0.000 claims 1
102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims 1
101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims 1
208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
206010047741 Vulval cancer Diseases 0.000 claims 1
208000004354 Vulvar Neoplasms Diseases 0.000 claims 1
208000008383 Wilms tumor Diseases 0.000 claims 1
GNNQKWGCFDPRQZ-UHFFFAOYSA-N [1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]pyrrolidin-3-yl] dihydrogen phosphate Chemical compound P(=O)(OC1CN(CC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)(O)O GNNQKWGCFDPRQZ-UHFFFAOYSA-N 0.000 claims 1
208000021841 acute erythroid leukemia Diseases 0.000 claims 1
208000037833 acute lymphoblastic T-cell leukemia Diseases 0.000 claims 1
208000013593 acute megakaryoblastic leukemia Diseases 0.000 claims 1
208000020700 acute megakaryocytic leukemia Diseases 0.000 claims 1
229940100198 alkylating agent Drugs 0.000 claims 1
239000002168 alkylating agent Substances 0.000 claims 1
239000004037 angiogenesis inhibitor Substances 0.000 claims 1
229940121369 angiogenesis inhibitor Drugs 0.000 claims 1
239000005557 antagonist Substances 0.000 claims 1
239000003242 anti bacterial agent Substances 0.000 claims 1
230000000340 anti-metabolite Effects 0.000 claims 1
230000000118 anti-neoplastic effect Effects 0.000 claims 1
229940088710 antibiotic agent Drugs 0.000 claims 1
229940100197 antimetabolite Drugs 0.000 claims 1
239000002256 antimetabolite Substances 0.000 claims 1
229940034982 antineoplastic agent Drugs 0.000 claims 1
229940041181 antineoplastic drug Drugs 0.000 claims 1
230000006907 apoptotic process Effects 0.000 claims 1
208000005980 beta thalassemia Diseases 0.000 claims 1
201000011143 bone giant cell tumor Diseases 0.000 claims 1
201000003714 breast lobular carcinoma Diseases 0.000 claims 1
230000022131 cell cycle Effects 0.000 claims 1
201000010881 cervical cancer Diseases 0.000 claims 1
230000001684 chronic effect Effects 0.000 claims 1
208000032852 chronic lymphocytic leukemia Diseases 0.000 claims 1
208000029742 colonic neoplasm Diseases 0.000 claims 1
125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
206010012601 diabetes mellitus Diseases 0.000 claims 1
208000033679 diabetic kidney disease Diseases 0.000 claims 1
125000002576 diazepinyl group Chemical group N1N=C(C=CC=C1)* 0.000 claims 1
208000035475 disorder Diseases 0.000 claims 1
229940079593 drug Drugs 0.000 claims 1
208000028715 ductal breast carcinoma in situ Diseases 0.000 claims 1
210000003038 endothelium Anatomy 0.000 claims 1
201000004101 esophageal cancer Diseases 0.000 claims 1
201000003444 follicular lymphoma Diseases 0.000 claims 1
206010017758 gastric cancer Diseases 0.000 claims 1
210000004907 gland Anatomy 0.000 claims 1
125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims 1
201000009277 hairy cell leukemia Diseases 0.000 claims 1
208000006454 hepatitis Diseases 0.000 claims 1
231100000283 hepatitis Toxicity 0.000 claims 1
210000003494 hepatocyte Anatomy 0.000 claims 1
125000004404 heteroalkyl group Chemical group 0.000 claims 1
125000000623 heterocyclic group Chemical group 0.000 claims 1
125000005885 heterocycloalkylalkyl group Chemical group 0.000 claims 1
239000002944 hormone and hormone analog Substances 0.000 claims 1
230000036039 immunity Effects 0.000 claims 1
239000002955 immunomodulating agent Substances 0.000 claims 1
201000004653 inflammatory breast carcinoma Diseases 0.000 claims 1
208000036971 interstitial lung disease 2 Diseases 0.000 claims 1
206010073096 invasive lobular breast carcinoma Diseases 0.000 claims 1
125000001786 isothiazolyl group Chemical group 0.000 claims 1
125000000842 isoxazolyl group Chemical group 0.000 claims 1
201000010982 kidney cancer Diseases 0.000 claims 1
208000003849 large cell carcinoma Diseases 0.000 claims 1
208000012987 lip and oral cavity carcinoma Diseases 0.000 claims 1
201000005202 lung cancer Diseases 0.000 claims 1
208000020816 lung neoplasm Diseases 0.000 claims 1
208000003747 lymphoid leukemia Diseases 0.000 claims 1
208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
230000004060 metabolic process Effects 0.000 claims 1
208000021039 metastatic melanoma Diseases 0.000 claims 1
231100000782 microtubule inhibitor Toxicity 0.000 claims 1
125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 claims 1
201000008026 nephroblastoma Diseases 0.000 claims 1
208000016065 neuroendocrine neoplasm Diseases 0.000 claims 1
201000011519 neuroendocrine tumor Diseases 0.000 claims 1
210000000440 neutrophil Anatomy 0.000 claims 1
102000037979 non-receptor tyrosine kinases Human genes 0.000 claims 1
108091008046 non-receptor tyrosine kinases Proteins 0.000 claims 1
208000002154 non-small cell lung carcinoma Diseases 0.000 claims 1
201000008968 osteosarcoma Diseases 0.000 claims 1
201000002528 pancreatic cancer Diseases 0.000 claims 1
208000008443 pancreatic carcinoma Diseases 0.000 claims 1
230000037361 pathway Effects 0.000 claims 1
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 1
229910052697 platinum Inorganic materials 0.000 claims 1
210000000557 podocyte Anatomy 0.000 claims 1
208000014081 polyp of colon Diseases 0.000 claims 1
230000001737 promoting effect Effects 0.000 claims 1
239000003207 proteasome inhibitor Substances 0.000 claims 1
239000000296 purinergic P1 receptor antagonist Substances 0.000 claims 1
125000004076 pyridyl group Chemical group 0.000 claims 1
201000009410 rhabdomyosarcoma Diseases 0.000 claims 1
206010039073 rheumatoid arthritis Diseases 0.000 claims 1
230000019491 signal transduction Effects 0.000 claims 1
230000011664 signaling Effects 0.000 claims 1
201000000849 skin cancer Diseases 0.000 claims 1
208000000587 small cell lung carcinoma Diseases 0.000 claims 1
206010041823 squamous cell carcinoma Diseases 0.000 claims 1
201000011549 stomach cancer Diseases 0.000 claims 1
201000003120 testicular cancer Diseases 0.000 claims 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
125000000335 thiazolyl group Chemical group 0.000 claims 1
206010044412 transitional cell carcinoma Diseases 0.000 claims 1
208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 1
201000005112 urinary bladder cancer Diseases 0.000 claims 1
201000005102 vulva cancer Diseases 0.000 claims 1
0 C*c(nc1*)c(*)c(*)c1C#N Chemical compound C*c(nc1*)c(*)c(*)c1C#N 0.000 description 2

JP2019517187A 2016-06-13 2017-06-13 Ｄｎｍｔ１の阻害剤としての置換ピリジン Active JP7051829B2 (ja)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US201662349227P	2016-06-13	2016-06-13
US62/349,227		2016-06-13
US201662393256P	2016-09-12	2016-09-12
US62/393,256		2016-09-12
US201662412343P	2016-10-25	2016-10-25
US62/412,343		2016-10-25
PCT/IB2017/053511 WO2017216727A1 (en)	2016-06-13	2017-06-13	Substituted pyridines as inhibitors of dnmt1

Publications (3)

Publication Number	Publication Date
JP2019517596A JP2019517596A (ja)	2019-06-24
JP2019517596A5 true JP2019517596A5 (2)	2020-07-27
JP7051829B2 JP7051829B2 (ja)	2022-04-11

Family

ID=59239935

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2019517187A Active JP7051829B2 (ja)	2016-06-13	2017-06-13	Ｄｎｍｔ１の阻害剤としての置換ピリジン

Country Status (20)

Country	Link
US (1)	US10975056B2 (2)
EP (1)	EP3468953B1 (2)
JP (1)	JP7051829B2 (2)
KR (1)	KR20190017030A (2)
CN (1)	CN109563043B (2)
AU (1)	AU2017283790B2 (2)
CA (2)	CA3026211A1 (2)
CL (1)	CL2018003577A1 (2)
CO (1)	CO2018013717A2 (2)
CR (1)	CR20180580A (2)
DO (1)	DOP2018000273A (2)
ES (1)	ES2993451T3 (2)
IL (1)	IL263163B (2)
JO (1)	JOP20180120A1 (2)
MA (1)	MA45244A (2)
MX (1)	MX391600B (2)
PE (1)	PE20190971A1 (2)
PH (1)	PH12018502633B1 (2)
SG (1)	SG11201809559UA (2)
WO (2)	WO2017216726A1 (2)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US11453697B1 (en)	2015-08-13	2022-09-27	Merck Sharp & Dohme Llc	Cyclic di-nucleotide compounds as sting agonists
KR102222186B1 (ko)	2015-08-13	2021-03-03	머크 샤프 앤드 돔 코포레이션	Sting 효능제로서 시클릭 디-뉴클레오티드 화합물
CA2968836C (en)	2016-06-13	2025-09-02	Gilead Sciences, Inc.	FXR MODULATING COMPOUNDS (NR1H4)
NZ748641A (en)	2016-06-13	2020-04-24	Gilead Sciences Inc	Fxr (nr1h4) modulating compounds
PT3523287T (pt)	2016-10-04	2021-10-06	Merck Sharp & Dohme	Compostos de benzo[b]tiofeno como agonistas de sting
SI4122464T1 (sl)	2017-03-28	2024-07-31	Gilead Sciences, Inc.	Terapevtske kombinacije za zdravljenje bolezni jeter
US11466047B2 (en)	2017-05-12	2022-10-11	Merck Sharp & Dohme Llc	Cyclic di-nucleotide compounds as sting agonists
RU2020109328A (ru)	2017-08-04	2021-09-06	Мерк Шарп И Доум Корп.	Комбинации антагонистов pd-1 и бензо[b]тиофеновых агонистов sting для лечения рака
JP2020530838A (ja)	2017-08-04	2020-10-29	メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋＳｈａｒｐ＆ＤｏｈｍｅＣｏｒｐ．	がん治療のためのベンゾ［ｂ］チオフェンＳＴＩＮＧアゴニスト
CN109651358B (zh) *	2017-10-11	2023-04-07	上海迪诺医药科技有限公司	4-氨基吡啶衍生物、其药物组合物、制备方法及应用
EP3727401A4 (en)	2017-12-20	2022-04-06	Merck Sharp & Dohme Corp.	CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS
EP3774765A4 (en)	2018-04-03	2021-12-29	Merck Sharp & Dohme Corp.	Aza-benzothiophene compounds as sting agonists
JP7326319B2 (ja)	2018-04-03	2023-08-15	メルク・シャープ・アンド・ドーム・エルエルシー	Ｓｔｉｎｇアゴニストとしてのベンゾチオフェン類及び関連する化合物
PT3911647T (pt)	2019-01-15	2024-03-04	Gilead Sciences Inc	Composto de isoxazole como agonista de fxr e composições farmacêuticas que o contenham
JP2022519906A (ja)	2019-02-19	2022-03-25	ギリアードサイエンシーズ，インコーポレイテッド	Ｆｘｒアゴニストの固体形態
CN113480541B (zh) *	2019-03-07	2022-09-02	湖南化工研究院有限公司	咪唑并吡啶化合物及其中间体的制备方法
WO2022076563A1 (en) *	2020-10-07	2022-04-14	University Of Florida Research Foundation, Incorporated	Macrocyclic compounds and methods of treatment
CA3212345A1 (en) *	2021-03-02	2022-09-09	Glaxosmithkline Intellectual Property Development Limited	Substituted pyridines as dnmt1 inhibitors
CN113502265B (zh) *	2021-05-25	2024-05-28	昭泰英基生物医药（香港）有限公司	将t细胞重编程为类nk细胞的诱导剂及其应用
CN113278021B (zh) *	2021-05-29	2022-09-23	天津全和诚科技有限责任公司	1,7-二氮杂螺[3.5]壬烷-7-甲酸叔丁酯及其草酸盐的制备方法
US11938143B2 (en)	2021-10-19	2024-03-26	Akirabio, Inc.	Compositions comprising 2′-deoxycytidine analogs and use thereof for the treatment of sickle cell disease, thalassemia, and cancers
CN114230459A (zh) *	2021-12-10	2022-03-25	武汉九州钰民医药科技有限公司	一种化合物的制备方法及分析检测方法
WO2023192629A1 (en) *	2022-04-01	2023-10-05	Herophilus, Inc.	Induction of mecp2 expression by dna methyl transferase inhibitors
WO2024156288A1 (en) *	2023-01-29	2024-08-02	Shanghai Kygent Pharmaceutical Co., Ltd	Dnmt1 inhibitors, pharmaceutical compositions, and therapeutic applications
WO2025006902A2 (en) *	2023-06-29	2025-01-02	Dana-Farber Cancer Institute, Inc.	Synthesis and in vitro characterization of proteolysis targeting chimeras (protacs) for degradation of dna methyltransferase 1 (dnmt1)
WO2025085756A1 (en) *	2023-10-18	2025-04-24	University Of Florida Research Foundation, Incorporated	Macrocyclic compounds and methods of treatment
WO2025190285A1 (en) *	2024-03-12	2025-09-18	Shanghai Kygent Pharmaceutical Co., Ltd	Pyridine compounds, pharmaceutical compositions, and applications
CN119306700A (zh) *	2024-08-28	2025-01-14	山东大学	Dnmt1-hdac双靶点抑制剂及其制备方法和应用

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2030875C (en)	1990-11-26	2002-07-02	Alan R.P. Paterson	Methods and probes for detecting nucleoside transporter and method for producing the probes
CA2075154A1 (en)	1991-08-06	1993-02-07	Neelakantan Balasubramanian	Peptide aldehydes as antithrombotic agents
ZA942125B (en)	1993-03-26	1994-11-10	Shell Res Ltd	Herbicidal heterocyclic compounds.
CZ203898A3 (cs)	1995-12-29	1999-03-17	Smithkline Beecham Corporation	Antagonista vitronektinového receptoru, farmaceutický přípravek s jeho obsahem, způsob a použití
WO1997024122A1 (en)	1995-12-29	1997-07-10	Smithkline Beecham Corporation	Vitronectin receptor antagonists
DE19947154A1 (de) *	1999-10-01	2001-10-04	Bayer Ag	Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
US20020052343A1 (en)	1999-12-15	2002-05-02	Allen Darin Arthur	Salicylamides as serine protease inhibitors
US6794506B2 (en)	2000-07-21	2004-09-21	Elan Pharmaceuticals, Inc.	3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
US20030166554A1 (en)	2001-01-16	2003-09-04	Genset, S.A.	Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
DE10110754A1 (de) *	2001-03-07	2002-09-19	Bayer Ag	Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
DE10134481A1 (de) *	2001-07-16	2003-01-30	Bayer Ag	Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung
DE10238113A1 (de) *	2001-12-11	2003-06-18	Bayer Ag	Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung
TW200406370A (en)	2002-06-28	2004-05-01	Syngenta Participations Ag	4-(3,3-Dihalo-allyloxy)phenoxy alkyl derivatives
TW200406152A (en)	2002-08-30	2004-05-01	Syngenta Participations Ag	4-(3,3-Dihalo-allyloxy) phenol derivatives having pesticidal properties
US6930117B2 (en)	2002-11-09	2005-08-16	The Procter & Gamble Company	N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
AR042344A1 (es)	2002-12-11	2005-06-15	Syngenta Participations Ag	Derivados de 4-(3,3 - dihalo - aliloxi) fenol con propiedades pesticidas
SE0203712D0 (sv)	2002-12-13	2002-12-13	Astrazeneca Ab	Novel compounds
JP4895806B2 (ja)	2003-04-09	2012-03-14	エクセリクシス，インク．	Ｔｉｅ−２モジュレータと使用方法
EP1627869B1 (en)	2003-05-20	2012-05-02	Ajinomoto Co., Inc.	Vanilloid receptor modulators
CN1856307A (zh)	2003-09-23	2006-11-01	默克公司	喹啉钾通道抑制剂
AU2011253934C1 (en)	2004-06-17	2013-08-22	Cytokinetics, Inc.	Substituted urea derivatives for treating cardiac diseases
US7776869B2 (en)	2004-10-18	2010-08-17	Amgen Inc.	Heteroaryl-substituted alkyne compounds and method of use
EP1655296A1 (en)	2004-10-25	2006-05-10	Graffinity Pharmaceuticals AG	Thrombin inhibitors
WO2006078752A2 (en)	2005-01-21	2006-07-27	Methylgene, Inc.	Inhibitors of dna methyltransferase
GB0517740D0 (en)	2005-08-31	2005-10-12	Novartis Ag	Organic compounds
US7825120B2 (en)	2005-12-15	2010-11-02	Cytokinetics, Inc.	Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas
CN101472895A (zh)	2006-06-20	2009-07-01	石原产业株式会社	含有新的吡啶基-甲胺衍生物或其盐的有害生物防除剂
US20080132525A1 (en)	2006-12-04	2008-06-05	Methylgene Inc.	Inhibitors of DNA Methyltransferase
AU2008211729A1 (en)	2007-02-01	2008-08-07	Astrazeneca Ab	5,6,7,8-tetrahydropteridine derivatives as HSP90 inhibitors
US20090011994A1 (en)	2007-07-06	2009-01-08	Bristol-Myers Squibb Company	Non-basic melanin concentrating hormone receptor-1 antagonists and methods
WO2009034433A2 (en)	2007-09-10	2009-03-19	Glenmark Pharmaceuticals, S.A.	3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands
JP5580201B2 (ja)	2007-10-08	2014-08-27	アドビヌス・セラピューティクス・プライベート・リミテッド	グルコキナーゼアクチベータとしてのアセトアミド誘導体、その製法及び医薬応用
US8343966B2 (en)	2008-01-11	2013-01-01	Novartis Ag	Organic compounds
UY31952A (es)	2008-07-02	2010-01-29	Astrazeneca Ab	5-metilideno-1,3-tiazolidina-2,4-dionas sustituidas como inhibidores de quinasa pim
WO2010007756A1 (ja) *	2008-07-14	2010-01-21	塩野義製薬株式会社	Ｔｔｋ阻害作用を有するピリジン誘導体
UY32055A (es)	2008-08-19	2010-03-26	Astrazeneca Ab	Derivados sustituidos de la 5-Halo-N2-[sustituido](1-metil-1H-imidazol-4-il)pirimidin-2,-diamina y sus sales farmacéuticamente aceptables, procesos de preparación, composiciones y aplicaciones.
WO2010048149A2 (en)	2008-10-20	2010-04-29	Kalypsys, Inc.	Heterocyclic modulators of gpr119 for treatment of disease
AR074760A1 (es)	2008-12-18	2011-02-09	Metabolex Inc	Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
WO2010088518A2 (en)	2009-01-31	2010-08-05	Kalypsys, Inc.	Heterocyclic modulators of gpr119 for treatment of disease
KR101146010B1 (ko) *	2009-09-10	2012-05-16	서울대학교산학협력단	ＴＮＦ-α 매개성 질환의 예방 및 치료용 조성물
US20120238557A1 (en)	2009-11-13	2012-09-20	Shionogi & Co., Ltd.	Aminothiazine or aminooxazine derivative having amino linker
NZ601267A (en)	2009-12-23	2014-03-28	Takeda Pharmaceutical	Fused heteroaromatic pyrrolidinones as syk inhibitors
PL2516425T3 (pl)	2009-12-23	2016-03-31	Jasco Pharmaceuticals Llc	Inhibitory kinaz aminopirydynowych
EP2338888A1 (en)	2009-12-24	2011-06-29	Almirall, S.A.	Imidazopyridine derivatives as JAK inhibitors
WO2011103289A2 (en)	2010-02-17	2011-08-25	Jasco Pharmaceuticals, LLC	Imidazole-2, 4-dione inhibitors of casein kinase 1
US8969349B2 (en)	2010-05-26	2015-03-03	Sunovion Pharmaceuticals Inc.	Substituted quinoxalines and quinoxalinones as PDE-10 inhibitors
WO2012040636A2 (en)	2010-09-24	2012-03-29	The Broad Institute, Inc.	Compounds and methods for treating diseases mediated by protease activated receptors
US20120184572A1 (en)	2011-01-13	2012-07-19	Metabolex, Inc.	Aryl gpr119 agonists and uses thereof
EP2665362B1 (en)	2011-01-17	2016-03-30	Karyopharm Therapeutics, Inc.	Olefin containing nuclear transport modulators and uses thereof
US20120316182A1 (en)	2011-06-10	2012-12-13	Calcimedica, Inc.	Compounds that modulate intracellular calcium
US20140256740A1 (en)	2011-07-29	2014-09-11	Tempero Pharmaceuticals, Inc.	Compounds and methods
EP2736329A4 (en)	2011-07-29	2015-03-25	Tempero Pharmaceuticals Inc	COMPOUNDS AND METHODS
WO2013062943A1 (en) *	2011-10-24	2013-05-02	Glaxosmithkline Intellectual Property Development Limited	New compounds
US9013997B2 (en)	2012-06-01	2015-04-21	Broadcom Corporation	System for performing distributed data cut-through
KR102215272B1 (ko)	2012-09-28	2021-02-15	이그니타, 인코포레이티드	비정형 단백질 키나제 c의 아자퀴나졸린 억제제
US9822115B2 (en)	2014-01-21	2017-11-21	Wockhardt Limited	Nitrogen containing compounds and their use as antibacterial agents
WO2015110999A1 (en)	2014-01-24	2015-07-30	Piramal Enterprises Limited	Ezh2 inhibitors and uses thereof

2017
- 2017-06-13 WO PCT/IB2017/053509 patent/WO2017216726A1/en not_active Ceased
- 2017-06-13 MX MX2018015483A patent/MX391600B/es unknown
- 2017-06-13 CA CA3026211A patent/CA3026211A1/en active Pending
- 2017-06-13 MA MA045244A patent/MA45244A/fr unknown
- 2017-06-13 PH PH1/2018/502633A patent/PH12018502633B1/en unknown
- 2017-06-13 ES ES17733902T patent/ES2993451T3/es active Active
- 2017-06-13 CR CR20180580A patent/CR20180580A/es unknown
- 2017-06-13 SG SG11201809559UA patent/SG11201809559UA/en unknown
- 2017-06-13 US US16/309,121 patent/US10975056B2/en active Active
- 2017-06-13 CN CN201780036908.XA patent/CN109563043B/zh active Active
- 2017-06-13 KR KR1020197000766A patent/KR20190017030A/ko not_active Ceased
- 2017-06-13 JP JP2019517187A patent/JP7051829B2/ja active Active
- 2017-06-13 WO PCT/IB2017/053511 patent/WO2017216727A1/en not_active Ceased
- 2017-06-13 EP EP17733902.5A patent/EP3468953B1/en active Active
- 2017-06-13 AU AU2017283790A patent/AU2017283790B2/en not_active Ceased
- 2017-06-13 PE PE2018003216A patent/PE20190971A1/es unknown
- 2017-06-13 CA CA3026226A patent/CA3026226A1/en not_active Abandoned
2018
- 2018-11-21 IL IL263163A patent/IL263163B/en unknown
- 2018-12-07 DO DO2018000273A patent/DOP2018000273A/es unknown
- 2018-12-10 JO JOP/2018/0120A patent/JOP20180120A1/ar unknown
- 2018-12-12 CL CL2018003577A patent/CL2018003577A1/es unknown
- 2018-12-18 CO CONC2018/0013717A patent/CO2018013717A2/es unknown

Publication	Publication Date	Title
JP2019517596A5 (2)	2020-07-27
JP7216682B2 (ja)	2023-02-01	Ｕｓｐ３０阻害剤としての１－シアノ－ピロリジン化合物
US12071428B2 (en)	2024-08-27	Indazole compounds as kinase inhibitors
ES2727376T3 (es)	2019-10-15	Derivados de aminotriazina útiles como compuestos inhibidores de quinasa de unión TANK
ES2523892T3 (es)	2014-12-02	Derivados triazol y utilización de los mismos para trastornos neurológicos
JP2022531801A5 (2)	2023-05-15
CN102112467B (zh)	2014-04-30	作为激酶抑制剂的嘧啶衍生物
ES2715325T3 (es)	2019-06-03	Derivados de 6-bencilo-6H-pirido[3.2-e][1.2.4]triazolo[1,5-c]pirimidina-5-ona y 6-bencilo-[1.2.4]triazolo[1,5-c]pteridina-5(6H)-ona como inhibidores de PDE1 para el tratamiento, p. ej. trastornos neurológicos
JP2024513881A (ja)	2024-03-27	オキサゼピン化合物及びがんの治療におけるその使用
BR112021008986A2 (pt)	2021-08-10	composto, composto da fórmula, composto ou sal farmaceuticamente aceitável, composição farmacêutica, métodos para tratar o câncer, para regular a atividade de uma proteína mutante g12c k-ras, para inibir a proliferação de uma população de células, para tratar um distúrbio mediado, para preparar uma proteína e para inibir metástase de tumor e uso
JP2022531801A (ja)	2022-07-11	フェニルアミノピリミジンアミドオートファジー阻害剤およびその使用方法
HRP20240293T1 (hr)	2024-05-24	Derivati kinazolina kao protutumorska sredstva
JP2010512338A5 (2)	2013-06-20
CN108430993A (zh)	2018-08-21	Tank-结合激酶抑制剂化合物
KR20190091537A (ko)	2019-08-06	C-kit 억제제로서의 아미노티아졸 화합물
JP2025540958A (ja)	2025-12-17	蕁麻疹の治療のための野生型ｃ－ｋｉｔキナーゼ阻害剤としてのＮ－フェニル－ピラゾロ［１，５－Ａ］ピリジン－３－カルボキサミド誘導体
RU2009125897A (ru)	2011-01-20	Ингибиторы фосфоинозитид-3-киназы и способы их применения
JP7250011B2 (ja)	2023-03-31	Ｐ２ｘ３阻害剤としての新規なピラゾロ－ピロロ－ピリミジン－ジオン誘導体
AU2010286569A1 (en)	2012-04-12	Compounds and compositions as protein kinase inhibitors
JP2019508384A (ja)	2019-03-28	５−置換２−（モルホリン−４−イル）−１，７−ナフチリジン
JP2017532360A5 (2)	2018-12-06
RU2017118165A (ru)	2018-11-29	Ингибиторы энхансера гомолога 2 zestes
AU2016270373A1 (en)	2018-01-04	Triazoles for the treatment of demyelinating diseases
JP2022544952A (ja)	2022-10-24	［１，２，４］トリアゾロ［１，５－ｃ］キナゾリン－５－アミン
JP7651590B2 (ja)	2025-03-26	アミノピリミジン誘導体およびアリール炭化水素受容体モジュレーターとしてのその使用